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ABSTRACT 
 
Little is known about the effects of protein-energy malnutrition (PEM) developing 
after stroke on brain recovery. The goal of this project was to develop two experimental models 
in the adult rat to allow evaluation of nutritional effects on post-stroke recovery: (1) a PEM 
model, and (2) a photothrombotic stroke model. 
Experiment 1 examined the hypothesis that a diet containing either 1% or 0.5% 
protein will produce an acute state of mild-moderate PEM in adult rats. Male, Sprague-Dawley 
rats (16 wk) were trained in the Montoya staircase before being randomized to diets containing 
0.5% (n=8), 1% (n=8), or 12.5% protein (n=10 [CON]) for 31d. Both low protein diets increased 
liver lipid content (p< 0.001) and decreased food intake (p= 0.005) and body weight (p< 0.001) 
compared to the 12.5% protein diet. The 0.5% protein group best mimicked the stroke patient, as 
judged by decreased serum albumin (p= 0.018) and an acute decrease in mean (±SEM) body 
weight (g) by d7 (0.5%= 424±15; 1%= 428±14; CON= 477±10; p = 0.011). Increased 
concentrations of the positive acute phase proteins, alpha-2-macroglobulin and alpha-1-acid 
glycoprotein, were greatest in the 0.5% group (p< 0.001). No differences were observed in the 
Montoya test on d3, 15, or 30 (p= 0.26). Values on d30 were: 0.5%= 109.5±4.4% of pre-diet 
performance; 1%= 97.2±5.5%; CON= 98.5±10.2%. 
Experiment 2 tested the hypothesis that targeted laser irradiation and 30 mg/kg of 
rose Bengal injection will cause an infarct in the forepaw region of the cortex with accompanying 
functional deficits. Male adult rats trained in the Montoya staircase were randomized to ISCHEMIA 
(n=15) or SHAM (n=3) surgery. A cortical infarct occurred in 86% of rats, with some misplacement 
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and variability in volume (5.7-12.8 mm3). Forepaw impairments were confirmed by decreased 
performance in the staircase at d3 (34.3±7.3 % of pre-stroke performance, p<0.001) and diminished 
use in the cylinder test (30.3±4.0% affected limb use versus 53.9±1.93% prestroke, p< 0.001). At 
d30, mean recovery was incomplete in the staircase (p< 0.001).  
These experimental models, with additional refinements, can be used to address the 
hypothesis that deteriorating nutritional status after a stroke interferes with brain recovery.  
 
 
  
iv 
 
ACKNOWLEDGMENTS 
 
 
My deepest gratitude is to my supervisor, Dr. Phyllis Paterson. Thank you for 
teaching me to question the world and express my ideas, this is true science. Thank you to the 
members of my committee, Chair Dr. Brian Bandy, Dr. Susan Whiting, and Dr. Gillian Muir for 
sharing your advice and expertise. A special thank you to Dr. Mariam Alaverdashvili for the help 
with histological analyses. 
Thank you to my colleagues who have always offered a helping hand; Shari Smith, 
Angela Cooper, LaRhonda Sobchishin and Erin Prosser-Loose. The greatest thank you to Sonia 
Cyrenne, for performing surgeries and guiding me in my laboratory work, I could not have done 
this without your help. 
I would like to acknowledge financial support from the Incentive Shared Funding 
Award, the University of Saskatchewan Graduate Research Fellowship and the Saskatchewan 
Innovation and Opportunity Scholarship. Research funding was provided by a Canadian 
Institutes of Health Research grant and a Heart and Stroke Foundation of Saskatchewan grant. 
I am ever grateful to God, for His strength during this research project. To my 
amazing parents Luciana and Henrique, and my brother Alexandre, thank you for your love, 
support and encouragement. To my best friend and husband, Arthur, for doing so much more 
than his share when I had to be “taking care of my rats”. To you, my deepest gratitude and my 
eternal love. Lastly, thank you to my beautiful daughter Clara, who always fixed everything with 
her smile. Your love makes it all worth it. 
v 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This thesis is dedicated to my inspiring parents, 
Henrique and Luciana Andrade, 
the hardest-working people I know. 
 
 
 
 
Genius is one percent inspiration and ninety-nine percent perspiration. 
 
Thomas Alva Edison 
 TABLE OF CONTENTS 
PERMISSION TO USE…………………………………………………………………………….i 
ABSTRACT………………………………………………………………………………………..ii 
ACKNOWLEDGEMENTS………………………………………………………………………..iv 
TABLE OF CONTENTS…………………………………………………………………….…....vi 
LIST OF TABLES…………………………………………………………………………………x 
LIST OF FIGURES…………………………………………………………………………...…..xi  
LIST OF ABBREVIATIONS…………………………………………………………………...xiii 
CHAPTER 1 INTRODUCTION ...................................................................................................... 1 
1.1 Rationale .......................................................................................................................... 1 
1.2 Hypotheses and Objectives .............................................................................................. 3 
CHAPTER 2 LITERATURE REVIEW ........................................................................................... 5 
2.1 Ischemic Stroke ............................................................................................................... 5 
2.1.1 Definitions and Prevalence ................................................................................. 5 
2.1.2 Mechanisms of Brain Injury ................................................................................ 6 
2.1.3 Advances in Acute Stroke Treatment .................................................................. 8 
2.1.4 Neuroplasticity, Spontaneous Brain Repair and Post-Stroke Therapy ................ 9 
2.2 Protein-Energy Malnutrition in the Stroke Patient ........................................................ 12 
2.2.1 Overview ........................................................................................................... 12 
2.2.2 Causes of PEM after Stroke .............................................................................. 14 
2.2.3 Diagnosis of PEM – Nutritional Assessment .................................................... 15 
vi 
 2.2.3.1 Nutritional History  ............................................................................... 16 
2.2.3.2 Anthropometric Measurements  ........................................................... 16 
2.2.3.3 Biochemical Assessment  ..................................................................... 17 
2.2.3.4 Inflammatory Markers  ......................................................................... 19 
2.2.3.5 Functional Assessments  ....................................................................... 19 
2.2.4 Proposed Mechanisms by which PEM Could Affect Brain Plasticity and 
Functional Outcome after Stroke  .............................................................................. 20 
2.3 Experimental Models to Study Post-Stroke PEM  ........................................................ 22 
2.3.1 Stroke Models  .................................................................................................. 22 
2.3.1.1 Focal Ischemia Models  ........................................................................ 23 
2.3.1.2 Sensorimotor Cortex  ............................................................................ 25 
2.3.1.3 Assessment of Brain Injury  .................................................................. 27 
2.3.2 Protein-Energy Malnutrition Models in the Rat  ............................................... 29 
CHAPTER 3 MODELLING POST-STROKE PROTEIN-ENERGY MALNUTRITION ….…30 
3.1 Introduction  .................................................................................................................. 30 
3.2 Materials and Methods  ................................................................................................. 33 
3.2.1 Experimental Design  ........................................................................................ 33 
3.2.2 Training in the Montoya Staircase  ................................................................... 34 
3.2.3 Motivation for Performance in the Montoya Staircase  .................................... 35 
3.2.4 Experimental Diets  ........................................................................................... 35 
3.2.5 Testing in the Montoya Staircase and Motivation Test  .................................... 35 
3.2.6 Characterization of the Malnutrition  ................................................................ 37 
3.2.6.1 Tissue Collection  ................................................................................. 37 
3.2.6.2 Serum Albumin Concentration  ............................................................ 37 
vii 
viii  
3.2.6.3 Liver Lipid Content  ............................................................................. 37 
3.2.6.4 Alpha-1-Acid Glycoprotein (AGP) and Alpha-2 Macroglobulin (A2M) 
Concentrations  ................................................................................................. 38 
3.2.7 Statistical Analysis  ........................................................................................... 38 
3.3 Results  .......................................................................................................................... 39 
3.3.1 Assessment of Protein-Energy Status  ............................................................... 39 
3.3.1.1 Body Weight  ........................................................................................ 39 
3.3.1.2 Food Intake  .......................................................................................... 39 
3.3.1.3 Liver Lipid Content  ............................................................................. 40 
3.3.1.4 Serum Albumin  .................................................................................... 41 
3.3.1.5 Serum Alpha-1-Acid Glycoprotein  ...................................................... 42 
3.3.1.6 Serum Alpha-2 Macroglobulin  ............................................................ 43 
3.3.2 Motor Skills Assessment  .................................................................................. 44 
3.3.2.1 Montoya Staircase Test  ........................................................................ 44 
3.3.2.2 Motivation to Reach for Sugar Pellets in the Montoya Staircase  ......... 45 
3.4 Discussion.  .................................................................................................................... 46 
CHAPTER 4 ESTABLISHING THE PHOTOTHROMBOTIC FOCAL ISCHEMIA MODEL . 51 
4.1 Introduction  .................................................................................................................. 51 
4.2 Materials and Methods  ................................................................................................. 54 
4.2.1 Experimental Design  ........................................................................................ 54 
4.2.2 Diet  ................................................................................................................... 55 
4.2.3 Montoya Staircase Training and Pre-Stroke Performance Assessment  ........... 55 
4.2.4 Cylinder Task: Pre-Stroke Performance Assessment  ....................................... 56 
4.2.5 Surgical Induction of Stroke  ............................................................................ 56 
ix  
4.2.6 Post-Stroke Functional Assessments: Montoya Staircase and Cylinder        
Testing …….……………………………………………………………….………………………….57  
 
4.2.7 4.2.7 Histological Assessment of Infarct Size………………………...…….....58 
4.2.8 Statistical Analyses………………………………………………………….....59 
4.3 Results ........................................................................................................................... 60 
4.3.1 Pre and Post-Surgical Outcomes ........................................................................ 60 
4.3.2 Histological Outcomes ...................................................................................... 62 
4.3.3 Behavioral Outcomes ......................................................................................... 65 
4.3.4 Relationship between Infarct Size and Behavioral Outcomes ........................... 68 
4.4 Discussion. ..................................................................................................................... 71 
CHAPTER 5 DISCUSSION ........................................................................................................... 75 
5.1 Conclusions ................................................................................................................... 75 
5.2 Strengths and Limitations .............................................................................................. 76 
5.3 Future Directions ........................................................................................................... 78 
LIST OF REFERENCES……………………………………………………………………..…..81 
x  
LIST OF TABLES 
Table 3.1 Composition of experimental diets…………………………………………..….……36 
Table 4.1 Summary of physiological variables monitored during surgery………………………61 
Table 4.2 Summary of lesion location and size for ISCHEMIA animals………………...……...65 
xi  
LIST OF FIGURES 
 
 
 
 
Figure 3.1 Mean (± SEM) body weight (g) measurements showed a group x time 
interaction……………………………………………………………………………………......39 
 
Figure 3.2 Food intake (mean ± SEM) of rats fed low protein diets was lower than that of control 
fed rats….……………………………………………………………………………….……….40 
 
Figure 3.3 Liver lipid content was increased by both low protein diets…………...………….…41 
 
Figure 3.4 Serum albumin concentration (mean ± SEM) was decreased by the 0.5% protein 
diet...…………………………………………………………………………………….…….…42 
 
Figure 3.5 Low protein diets elevated mean (± SEM) serum alpha-1-acid glycoprotein 
concentration and 0.5% protein had the largest effect...……………………………………...…43 
 
Figure 3.6 A diet containing 0.5% protein elevated mean (± SEM) serum A2M concentrations 
to a greater extent than a 1% protein diet…………..…………………………………………....44 
 
Figure 3.7 Low protein diets did not alter performance in the Montoya staircase after 3, 15 or 30 
days of exposure to experimental diet………………………………………………………...…45 
 
Figure 3.8 All experimental groups ate the sugar pellets more quickly with increased exposure to 
them, but this was not significantly altered by experimental diet……………………….…...….46 
 
Figure 4.1 Body weight (g) during the experimental period…………………………..………...61 
 
Figure 4.2 Variation in total volume of infarct (mm3) among rats exposed to photothrombotic 
stroke……………………………...……………………………………………………………..62 
 
Figure 4.3 Photographs of coronal sections taken at the core of the infarct for 2 animals located 
at ~0.5mm from Bregma……………………………………………………………….…….... 63 
 
Figure 4.4 Representation of the location of infarct in the brain cortex of those ISCHEMIA rats 
with an observable infarct in comparison to the intended placement……………..……..……... 64 
 
Figure 4.5 Area and regional distribution of two sample brains with the largest and smallest 
infarcts represented in coronal diagrams……………………………...…………...………….....64 
 
Figure 4.6 Reaching success in the Montoya staircase test was impaired after stroke and 
improved over time, but there was incomplete recovery by d30…..……………...….…………66 
 
Figure 4.7 ISCHEMIA rats used their affected limb for support in the cylinder significantly less 
after stroke  and improved function significantly over 30 days…..………..…………………... 67 
xii  
 
Figure 4.8 Pattern of limb use in the ISCHEMIA group for postural support in the cylinder was 
significantly different over time…………………………………………………………………68 
 
Figure 4.9 The d3 deficit in the Montoya staircase significantly increased with increasing infarct 
volume in rats following photothrombotic stroke…………………………………………….....69 
 
Figure 4.10 The d15 deficit in the Montoya staircase was not significantly correlated with infarct 
volume in rats following photothrombotic stroke………………………………………..….….69 
Figure 4.11 The deficit in the Montoya staircase on d 30 after photothrombotic stroke was not 
significantly correlated with infarct volume………………………………………………………70 
Figure 4.12 The deficit in the cylinder test on d3 after photothrombotic stroke was significantly 
correlated to infarct volume ………………………...…………………………………………....70 
Figure 4.13 The deficit in the cylinder test on d30 after photothrombotic stroke did not show 
significant correlation with infarct volume ……………...………………….……………………….71 
xiii  
LIST OF ABBREVIATIONS 
A2M 
AGP 
AIN-93M 
AMP 
AMPA 
ATP 
BDNF 
BMI 
CA3 
DNA 
FGF-2 
GABA 
GAP-43 
HSD 
IGF-1 
MAP-2 
MCA 
MCAO 
mRNA 
NMDA 
OCT 
PBS 
PEM 
 
Alpha-2-macroglobulin 
Alpha-1-acid glycoprotein 
American Institute of Nutrition 1993 Maintenance diet 
Adenosine monophosphate 
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
Adenosine triphosphate 
Brain-derived neurotrophic factor 
Body mass index 
Cornu ammonis 3 
Deoxyribonucleic acid 
Fibroblast growth factor-2 
Gamma-aminobutyric acid 
Growth-associated protein 43 
Honest significant difference 
Insulin growth-factor 1 
Microtubule- associated protein-2 
Middle cerebral artery 
Middle cerebral artery occlusion 
Messenger ribonucleic acid 
N- methyl-D-aspartic acid 
Optimal cutting temperature 
Phosphate buffered saline 
Protein-energy malnutrition 
xiv  
RNA  Ribonucleic acid 
SEM  Standard error of the mean 
STAIR  Stroke Therapy Academic Industry Roundtable  
t-PA        Tissue plasminogen activator 
trkB  Tropomyosin-related kinase B  
VLDL        Very low density lipoprotein 
 
 
 
 
 
1  
CHAPTER 1 
INTRODUCTION 
 
1.1 Rationale 
Stroke is a leading cause of disabilities worldwide. In Canada, 25% of stroke cases 
lead to either death or complete recovery, and the remaining 75% of patients are left with some 
form of impairment (Statistics Canada 2011). The current treatment for acute stroke, the 
thrombolytic agent tissue plasminogen activator (t-PA), has a very small window of 
administration (up to 4.5 hours after infarction) (Lindsay, Gubitz et al. 2011). Thus, stroke 
treatment often cannot be administered, which leaves patients with serious brain damage and 
severe impairments. Most research to date has attempted to reduce this disability with 
neuroprotective treatments that target a single pathway in the complex ischemic cascade 
responsible for brain cell death, and all clinical attempts have, thus far, failed (Ginsberg 2009). 
Current research strategies include: [1] combination treatments that target multiple pathways 
responsible for brain cell death (Savitz, Fisher 2007, Ginsberg 2008), and [2] novel approaches 
that aid brain recovery and repair mechanisms causing functional improvement (Cramer 2008, 
Murphy, Corbett 2009). 
Although a critical component of stroke care, nutritional status and interventions are 
not often contemplated in stroke treatment and research (Gariballa, Parker et al. 1998a, Shen, 
Chen et al. 2011). Protein-energy malnutrition (PEM), for instance, develops after stroke in 35- 
49% of patients (Poels, Brinkman-Zijlker et al. 2006, Finestone, Greene-Finestone et al. 1995), 
and is characterized by deficient protein and energy status. There have been studies suggesting 
that PEM negatively affects outcome after human stroke (Martineau, Bauer et al. 2005, Yoo, 
Kim et al. 2008), indicating that PEM may be an important stroke co-morbidity factor. Our 
laboratory has shown that some of the mechanisms through which the poor nutritional status 
affects outcome after brain ischemia involve components of the cascade leading to brain cell 
death (Bobyn, Corbett et al. 2005). The influence of continued PEM after stroke also includes 
alterations in plasticity proteins that are important to brain repair (Prosser-Loose, Verge et al. 
2010). Even though these studies acknowledge the importance of nutritional status to stroke 
development, functional outcome, and brain repair, they have all addressed the significance of 
pre-existing PEM that is already present at the time of stroke. This is a problem that affects 
approximately 16% of patients (Martineau, Bauer et al. 2005, Davis, Wong et al. 2004). While 
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the latter is an important issue, the post-stroke PEM is an even more severe problem, considering 
the dramatic increase in the rate of malnutrition that develops in the post-stroke period (Shen, 
Chen et al. 2011, Yoo, Kim et al. 2008, Axelsson, Asplund et al. 1988). 
Suboptimal nutritional status developing after stroke could be of crucial importance 
since any spontaneous neurological repair that occurs usually does so within three months 
(Cramer 2008). During this period, both anatomical and functional brain reorganization occurs, 
allowing for brain repair and recovery. These changes are known as neuroplasticity or plasticity 
(Murphy, Corbett 2009, Bergado-Rosado, Almaguer-Melian 2000, McEwen, Chattarji 2004). 
Mechanisms that contribute to this spontaneous repair include [1] axonal and dendritic growth 
(by elongating or sprouting mechanisms) of surviving neurons, [2] use of alternative brain 
circuits, and [3] neurogenesis (Bayona, Bitensky et al. 2005, Kreisel, Hennerici et al. 2007). 
Repair mechanisms and recovery itself are determined by the cause and the size of the stroke, but 
also by molecular processes and external factors (Cramer 2008). This period after stroke is, thus, 
central in the determination of stroke outcome. My overarching hypothesis driving the 
development of the animal models in this thesis is that PEM that develops after ischemic stroke 
will impair motor neuroplasticity. 
The use of experimental animals is an excellent way to mimick human disorders and 
to understand the underlying mechanisms, as well as to study novel treatments (Lieschke, Currie 
2007). The use of a rat model to simulate the malnourished post-stroke patient would allow for 
the study of this hypothesis. However, this model does not exist and the development of such a 
prototype requires the combination of two components:[1] a rat stroke model, such as 
photothrombotic stroke, that is well-established in the literature (Watson, Dietrich et al. 1985, 
Dietrich, Busto et al. 1987, Watson 1998, Diederich, Quennet et al. 2012, Jablonka, Burnat et al. 
2010, Sulejczak, Ziemlinska et al. 2007), and [2] a model of PEM suitable for mimicking that 
observed in the post-stroke patient. 
Unfortunately, there are no established standards of nutritional status for modelling 
PEM in rats. To mimick the features of the nutritional status of stroke patients, it is important to 
consider factors such as diet formulation and type of animal (Woodward 1998). Although there 
are numerous studies modeling PEM in rats, most use weanling and adolescent rats, which are 
rapidly growing (Prosser-Loose, Smith et al. 2011, Heard, Frangi et al. 1977, de Belchior, Angeli 
et al. 2012). However, PEM in the adult rat is not nearly as well characterized. Therefore, a study 
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was needed to determine the dietary regimen that induces PEM in adult rats that would mimick 
the clinical situation. The age of rat determines the protein requirement (Reeves, Nielsen et al. 
1993). Definition of the level of dietary protein to achieve the desired acute mild-moderate PEM 
in adult rats was, thus, necessary. This research is described in Chapter 3. 
The choice of photothrombosis to produce stroke in the rat was based on several 
characteristics of this model that allow for reproducible lesions in the cortex, with consequent 
alterations in sensorimotor function (Dietrich, Busto et al. 1987, Brown, Marlowe et al. 2003). 
This model shows good consistency for both anatomical (Jablonka, Burnat et al. 2010,  
Minnerup, Kim et al. 2011) and functional outcomes (Sulejczak, Ziemlinska et al. 2007, Shanina, 
Schallert et al. 2006, Moon, Alaverdashvili et al. 2009). Also, this model requires less surgical 
intervention than most experimental models of stroke and no craniotomy (Watson, Dietrich et al. 
1985). This is important for studying the effect of PEM on stroke outcome, since there will be 
fewer metabolic alterations associated with the surgery. After establishing the surgical procedure 
necessary for this model in our laboratory, the endpoints that needed development were the 
assessment of infarct volume and function. The use of well-validated behavioral tests to assess 
motor function at chosen endpoints helps to determine the stroke model reliability (Fisher, 
Feuerstein et al. 2009) and also will allow future evaluation of the influence of nutritional status 
on post-stroke functional outcome. Chapter 4 describes the methodological development of these 
endpoints. 
 
1.2 Hypotheses and Objectives 
Experiment 1 (Chapter 3) 
Hypothesis: A diet containing either 1% or 0.5% protein will produce an acute state of mild- 
moderate PEM in adult rats that models post-stroke protein-energy malnutrition. 
Objectives: 
 
a) To characterize the protein-energy status of rats fed diets containing 0.5% or 1% 
protein on the basis of body weight, food intake, liver lipid content, and serum acute phase 
protein concentrations. 
b) To test if PEM causes motor alterations in the rat, which could confound the 
Montoya staircase task for future assessments of functional abnormalities caused by cortical 
stroke. 
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c) To further validate the use of the Montoya staircase for assessing protein-energy 
malnourished rats by testing if motivation to obtain a sugar pellet is altered as the malnutrition 
develops. 
 
Experiment 2 (Chapter 4) 
Hypothesis: Targeted laser irradiation at an intensity of 25mW for 10 minutes combined with 30 
mg/kg of rose Bengal will result in a medium-size infarct located in the region of the cortex 
corresponding to forepaw function. The resulting infarct will cause motor alterations of the 
targeted forelimb. 
 
Objectives: 
a) To determine the reliability of the model by measurements of infarct volume. 
b) To evaluate the extent and consistency of the motor alterations by behavioural 
assessments. 
c) To determine if functional recovery is incomplete after 30 days. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
2.1 Ischemic Stroke 
2.1.1 Definitions and Prevalence 
The term stroke refers to a clinical syndrome that includes infarction and 
hemorrhage, causing sudden loss of brain function (Whisnant, Bas et al. 1990). In Canada, 
between 40,000 and 50,000 people have strokes each year; approximately 16,000 die from stroke, 
and about 29,000 are left with impairments. In 2011, it was estimated that stroke costs the 
Canadian economy $ 3.6 billion a year, each acute stroke costs about $27,500 (Statistics Canada 
2011). 
Approximately 20% of strokes are due to bleeding in the brain (Lloyd-Jones, 
Adams et al. 2009), and this type of stroke is known as hemorrhagic stroke. The clinical 
characteristics of hemorrhagic stroke depend on the location and severity of bleeding (Choi 
1990). Some people may have aneurysms present from early life, which weakens blood vessels, 
causing them to rupture in the presence of hypertension (Ding, Clark 2006). 
The remaining 80% of strokes, known as ischemic strokes, are caused by an 
interruption of blood flow to the brain (Lloyd-Jones, Adams et al. 2009) and are the subject of 
this thesis. The accumulation of atherosclerotic plaque (calcium, scar tissue and lipid materials) 
narrows the arteries that supply blood to the brain and can interfere with or completely block 
normal flow. Hyperlipidemia and inflammation are major contributors to the development of 
atherosclerosis. Hypercholesterolemia, for instance, helps to promote migration of circulating 
monocytes into the atherosclerotic lesion, where they help to form and develop the plaque as 
well as destabilize it. This endothelial pathophysiology is the main trigger of ischemic stroke 
(Libby, Ridker et al. 2011). An ischemic stroke is caused by either a thrombus or an embolism. 
Thrombotic stroke is caused by a clot that forms in an artery supplying the brain. When blood 
flow decreases in the affected artery, the collateral circulation maintains brain function. When 
the compensatory mechanism of collateral circulation fails, perfusion is compromised, leading to 
decreased blood flow and the death of neurons. Embolic stroke occurs when the clot forms 
elsewhere in the body and is carried through the blood stream to lodge in cerebral vessels 
(Adams, Bendixen et al. 1993). Microemboli can break away from a plaque from cardiac 
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sources, such as in atrial fibrillation (Warlow, Dennis et al. 2001).  
 
2.1.2 Mechanisms of Brain Injury 
The pathogenesis of ischemic stroke involves a complex cascade of mechanisms that 
lead to brain injury. The severity of the stroke depends on the region of infarct, the length of 
blood cessation and other secondary insults caused by reperfusion (reviewed in Doyle, Simon et 
al. 2008). 
Neuronal and glial cell death contribute to the pathology of stroke-induced brain 
injury. Two main categories are defined to describe brain cell death: [1] necrosis, when there is a 
loss of ionic homeostasis, swelling of the cell and its organelles, and loss of membrane integrity; 
[2] apoptosis, which presents with diminished cell volume, maintenance of organelle structure, 
and cytoplasmic and nuclear condensation and fragmentation (Fink, Cookson 2005). 
Morphological characteristics of necrotic neurons can be seen after brain ischemia, for instance 
plasma membrane failure and swelling of organelles and cell bodies. Apoptotic features are also 
apparent, including chromatin condensation, decreased cell size and deoxyribonucleic acid 
(DNA) fragmentation (Lee, Zipfel et al. 2000). 
The acute ischemic cascade responsible for neuronal death following stroke happens 
when the brain lacks glucose and oxygen in the area supplied by the occluded artery. This causes 
adenosine triphosphate (ATP) depletion, depolarization of membranes, glutamate excitotoxicity, 
calcium toxicity, oxidative stress and an inflammatory response (Hossmann 2006). Ischemia 
causes depolarization of the neuronal membranes, and an increase in neurotransmitter release. In 
the case of glutamate, it overstimulates the N-methyl-D-aspartic acid (NMDA)-type, as well as 
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate-type 
ionotropic receptors present in the pre- and post-synapses. This causes an increased influx of 
calcium that causes an overload of mitochondrial calcium and activation of Ca2+-dependant 
 
enzymes (Choi 1988). Metabotropic glutamate receptors activate inositol triphosphate dependant 
signal transduction pathways. Likewise, metabotropic receptors are a part of the regulatory 
cascade in glutamate release and re-uptake via cyclic- adenosine monophosphate (AMP) 
signalling. Because cyclic-AMP needs ATP to function, and in ischemia there is ATP depletion, 
glutamate regulation is impaired (Hazell 2007). Another glutamate regulator is the astrocyte. This 
type of glial cell takes up extracellular glutamate via ATP- dependent receptors present on the 
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membranes. Due to excessive intracellular Ca2+, in the ischemic brain, there is a reversal of these 
receptors that causes additional glutamate efflux, contributing to the excitotoxicity (Hazell 2007). 
Metabolic demand is increased in the area of the infarct, and ATP is further depleted, leading to 
additional glutamate liberation. This pathway results in neuronal necrosis, since neurons swell 
due to influx of Na+, Ca2+, Cl- and H2O (reviewed in Lee, Zipfel et al. 1999). Further NMDA 
activation leads to mitochondrial failure due to the Ca2+ overload. Proteases, endonucleases and 
phospholipases are activated since they are Ca2+-dependent enzymes. Calpain-1, a protease 
activated by calcium, leads to breakdown of structural proteins in the brain (Choi 1990). 
Endonucleases cause DNA cleavage, and the activated phospholipases break down membrane 
phospholipid and produce reactive oxygen species (Hazell 2007). Nitric oxide production, which 
results from nitric oxide synthase activity, is also increased in neurons in response to the Ca2+ 
overload and that also augments the production of reactive oxygen species (Hazell 2007). 
Reperfused areas, in which blood flow has been re-established, or areas with low 
blood perfusion are responsible for secondary damage since the blood brings with it high oxygen 
content and an accumulation of inflammatory cells (Ding, Clark 2006). Formation of reactive 
oxygen species causes injury to the plasma membrane and organelles. The injury to the 
mitochondria provokes release of cytochrome C that, once freed, promotes the apoptotic cell 
death cascade (Doyle, Simon et al. 2008, Fink, Cookson 2005). 
Inflammation also follows ischemic injury and contributes to its progression. Pro- 
inflammatory cytokines such as Interleukins- 1, 6 and 10 are secreted after glial cells are 
activated (Durukan, Tatlisumak 2007). Neurons and endothelial cells also produce inflammatory 
cytokines in response to ischemia that further injure neuronal tissue. Since there is evidence of 
increased cytokine concentrations in the brain and in the circulation hours after ischemia, they 
are believed to be the initiators of the inflammatory response after stroke (Ahmad, Graham 
2010). Under normal conditions, the blood-brain barrier prevents the infiltration of 
inflammatory molecules. However, after stroke, the brain becomes susceptible to inflammatory 
reactions (Danton, Dietrich 2003). The infiltration of neutrophils allows adhesion to the 
microvasculature and an increase in the endothelial permeability that can disrupt the blood-brain 
barrier and allow monocytes, macrophages and neutrophils to enter. In the brain, these cells can 
occlude the microvasculature and produce nitric oxide, reactive oxygen species and prostanoids, 
all toxic to the brain (Ding, Clark 2006). 
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Conversely, some inflammatory cells can be beneficial to the brain after stroke. They 
can remove cellular debris, repair tissue, and prevent additional neuronal damage. Astrocytes 
also play a protective role. They respond to stroke by a process referred to as reactive gliosis, 
which involves changes in their molecular expression and morphology, as well as a scar 
formation. Recent studies have shown that the glial scar may have a range of essential 
neuroprotective and repair-related functions, such as controlling the dissemination of 
inflammation (reviewed in Sofroniew 2009). The role of inflammation in brain injury is 
dependent on the severity of inflammation and the timing after stroke. Interleukin-10 for 
instance, has been shown to have neuroprotective effects on the ischemic brain (Grilli, Barbieri 
et al. 2000, Froen, Munkeby et al. 2002). Microglia can also have protective effects since they 
have a role in removing dead neurons, even though they also produce reactive oxygen species 
and cytokines (Lai, Todd 2006). 
The mechanisms and molecular pathways that lead to either type of cell death after 
stroke have formed the basis for developing pharmacological neuroprotective treatment to be 
administered immediately after stroke, a strategy that has largely failed (Faden 2002, Albers, 
Goldstein et al. 2011). 
 
2.1.3 Advances in Acute Stroke Treatment 
Currently, the only successful treatment for ischemic stroke is the tissue- 
plasminogen activator, a thrombolytic agent, which breaks up the clot and allows the 
reestablishment of the blood flow, or reperfusion (Fisher, Feuerstein et al. 2009). However, to be 
effective, this treatment has to be administered within 4.5 hours after the stroke (Lindsay, Gubitz 
et al. 2011). Unfortunately, patients do not always go to the hospital at the onset of symptoms, or 
they do not recall the exact time when symptoms started. After the patients are admitted to the 
hospital, they are assessed and undergo blood tests and brain imaging. Several tests are required 
prior to the intravenous injection of t-PA to exclude the possibility of hemorrhagic stroke, which 
is a critical exclusion criterion (Brott, Bougousslavsky 2000). The physician then explains the 
situation and the drug to the patients and families, and must obtain their understanding and 
approval before administering the drug. There is often not enough time to safely treat the patients 
with t-PA (Liang, Lew et al. 2008). The current acute stroke-management thus leaves the vast 
majority of patients untreatable. It was estimated in 2007 that, in Canada, less than 2% of stroke 
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patients actually received t-PA (Yip, Demaerschalk 2007). 
Outside the area of minimum blood flow in the infarct core, there is an area 
composed of tissue with less reduction in blood flow that can be salvaged if blood flow can be 
re-established; this is called the penumbra. There have been decades of research attempting to 
develop neuroprotective agents that could reduce brain damage by protecting neurons in the 
penumbra. Nonetheless, the achievements made in this field with experimental animal models 
have not successfully translated to clinical trials with positive outcomes (Ginsberg 2009). A 
commonly accepted criticism is that most neuroprotective strategies have failed because they 
target a single pathway in a very complex ischemic cascade, whereas novel neuroprotective 
approaches that target multiple pathways are likely to be more successful (Albers, Goldstein et 
al. 2011). Other reasons for the unsuccessful translation of neuroprotective approaches include: 
[1] failure to include essential design features in clinical trials, such as adequate dose, adequate 
follow-up period with significant outcomes, and early time window to initiate treatment; [2] 
clinical trial testing of agents for which preclinical efficacy was not replicated; and [3] use of 
agents at such high doses that they could not be safely used in humans (Mergenthaler, Meisel 
2012). 
 
2.1.4 Neuroplasticity, Spontaneous Brain Repair and Post-Stroke Therapy 
After stroke, the brain is capable of some spontaneous recovery, and that is partly 
due to resolution of edema and recovery of tissue function in areas that were not destroyed. This 
part of recovery occurs within a few days. Beyond this point, recovery is possible through 
neuroplasticity (reviewed in Hallett 2001). The term neuroplasticity refers to both anatomical 
and functional alterations of the brain in response to the ischemic insult, which allow for repair 
and recovery. Plastic changes can occur in either the contralateral or ipsilateral hemisphere or in 
both of them simultaneously. The ipsilateral hemisphere refers to the side where the infarct 
occurs, whereas the term “contralateral” refers to the other hemisphere. 
Improved functional performance does not necessarily reflect true recovery. After 
stroke, it is common to see behavioural compensation (Whishaw 2000, Finger, Almli 1985, 
Levin, Kleim et al. 2009). In rats, for example, impairments in grasping ability and supination of 
the forelimb after cortical stroke are counterbalanced by adjustments in posture, allowing the 
animal to perform similarly to pre-stroke levels (Moon, Alaverdashvili et al 2009). True recovery 
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is possible when the lesion is very small and the neurons needed for that function are saved from 
damage, or the residual brain tissue can support rewiring of the circuits responsible for a 
particular function (Moon, Alaverdashvili et al. 2009, Friel, Nudo 1998, Plautz, Milliken et al. 
2000). Another possibility for true recovery is when there is replacement of the injured circuitry, 
which is only possible with novel treatments such as the use of stem-cells, which is under intense 
investigation and still needs further research to answer questions with respect to cell line, timing 
of transplantation, route of administration, and safety (Kokaia, Martino et al. 2012, Kolb, Gibb 
2007, Lee, Kim et al. 2006). Thus, the term recovery refers to not only true recovery, but is also 
commonly used to describe mechanisms that improve performance through compensatory 
behavior (Buurke, Nene et al 2008). The plasticity mechanisms described below consider 
recovery simply as improved performance, and refer to both true recovery and compensation. 
It has been suggested that new stroke research should focus on understanding the 
mechanisms that lead to functional recovery, because of the possibility of enhancing the 
naturally occurring capabilities of the brain to recover (Murphy and Corbett 2009). However, 
mechanisms of plasticity are not completely understood because brain function is a complex 
system. Thus, recovery after a stroke comprises changes in cells and in the entire network 
(Jiang, Zhang et al 2010). The reorganization of neuronal routes following ischemia relies upon 
some of the same mechanisms occurring in the development of the brain and during changes 
related to experience, such as learning (Murphy and Corbett 2009). 
One plasticity mechanism after stroke is called unmasking. Neurons have a larger 
anatomical connectivity than utilized functionally, and the zones not in use are kept inhibited. 
When other areas fail, there is cessation of that inhibition and a new area of interest is unmasked 
(Jacobs, Donoghue 1991). Also, synaptic connections can be strengthened after stroke by 
processes of long-term potentiation or long-term depression. Some synaptic remodelling also 
occurs. Synaptic plasticity results in the sculpting of synaptic connections via an activity-
dependent process, which includes changes in the molecular level, as well as formation of new 
synapses. AMPA receptors at a synapse can control the coupling strength between neurons in the 
pre- and post-synapse, and thus serve as control for neural function. The presence of these 
receptors at a synapse has been shown to represent recent plasticity (Takahashi, Svoboda et al 
2003). Neuroplastic events are also assisted by chemical changes in neurotransmitters, growth 
factors, hormones and neurotrophins that promote survival and growth of neurons, as well as 
11  
remodelling of synapses (Johansson 2000). 
Other mechanisms that contribute to brain plasticity include axonal and dendritic 
changes related to surviving neurons. Axonal plasticity, which occurs under physiological 
conditions, also contributes to brain repair. It includes molecular changes in transmission and 
structural changes, such as sprouting and regeneration (Leenders, Sheng 2005). Because several 
molecules are involved in the regulation of vesicle exocytosis for neurotransmitter release across 
the synapse, many of them have roles in the plasticity of the pre-synapse (Leenders, Sheng 
2005). Protein kinase C and protein kinase A are examples of enzymes believed to be involved 
in pre-synaptic plasticity. Their role is to phosphorylate proteins involved in vesicle liberation 
(Leenders and Sheng 2005). There is also the growth of axonal branches following stroke. 
Growth factors and neurotrophins enhance the formation of side branches from axons to a new 
target (Gogolla, Galimberti et al 2007). Pre-synaptic function is highly altered because of the 
increase in intracellular Ca2+ after stroke. Pre-synaptic proteins involved in the regulation of 
 
synaptic function cause a decrease in the number of vesicles for neurotransmission (Kovalenko, 
Osadchenko et al 2006). 
Plasticity of dendrites is related to changes in structure, shape, and changes in 
receptor type (Luscher, Nicoll et al 2000). Structural changes related to recovery of function 
after stroke are also associated with changes in structure and shape of dendrites (Kolb, 
Muhammad et al. 2011, Kolb, Teskey et al. 2010). One study showed an increase in dendritic 
length after ischemia, which was suggested to be due to sprouting of new dendrites rather than 
extension of existing ones (Ruan, Lei et al 2009). Structural proteins are involved in recovery of 
synaptic transmission by restructuring of damaged dendrites after the ischemic insult (Briones, 
Woods et al 2006). Induction of microtubule-associated protein-2 (MAP-2) in regions adjacent 
to an infarct is believed to be a protective response of the brain. Also, increased MAP-2 
expression is observed in the penumbra, which indicates regrowth and restructuring of dendrites 
after stroke. Therefore, MAP-2 is considered a marker of dendritic plasticity (Li, Jiang et al 
1998). 
Besides altering the existing neurons and synapses, stroke also induces the 
proliferation of endogenous neural progenitor cells and an increase in the number of immature 
neurons (Jin, Minami et al 2001). New cells, adjacent to the infarct, will most likely mature as 
neurons. It has been observed that these cells express markers of mature neurons, including the 
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neuronal-specific nuclear protein (Parent, Vexler et al 2002). There is migration of neuroblasts 
into the injured area with the help of reactive astrocytes and blood vessels (Yamashita, Ninomiya 
et al 2006). One group showed that angiogenesis is linked to neurogenesis (Carmichael 2005; 
Tsai, Ohab et al 2006). Blood vessels upregulate angiopoietin 1 and stromal-derived factor 1, and 
their actions recruit immature neurons into the infarcted cortex. Upregulated angiopoietin 1 and 
stromal-derived factor 1 recruit immature neurons into the injured area of the cortex and cause 
improved behavioral recovery in the period after stroke (Carmichael 2005). 
Although studies of plasticity mechanisms are extremely valuable for understanding 
brain repair, all of these trials have ignored the potential influences of co-morbidity factors 
commonly present in stroke patients, such as PEM. The presence of PEM could affect post- 
stroke functional outcome or alter the efficacy of rehabilitation strategies through direct effects 
on neuroplasticity mechanisms. This topic is directly addressed below in Section 2.2.4. 
Therefore, the research described in this thesis is aimed at the methodological development 
required to address such questions in a well-controlled rat model of the malnourished stroke 
patient. 
 
2.2 Protein-Energy Malnutrition in the Stroke Patient 
2.2.1 Overview 
The extent of brain damage caused by stroke and the ability of the brain to recover is 
influenced by co-morbidity factors, and malnutrition is hypothesized to be one of them. Lack of 
or insufficient intake of nutrients leads to malnutrition (World Food Programme (WFP), Centers 
for Disease Control and Prevention (CDC) 2005). The body adapts to a reduced intake with a 
corresponding decrease in activity and increase in the use of energy reserves (muscle and fat). 
Therefore, a malnourished status will result in thinner individuals (Prudhon 2002). The most 
common form of malnutrition is protein-energy malnutrition (PEM), which refers to a combined 
deficiency of both protein and energy. All forms of PEM can occur as primary or secondary 
conditions (Woodward 1998). 
Acute diseases, such as stroke, can have an important effect on patients’ nutritional 
status. Poor nutritional status has been associated with poor survival and functional outcome 
following stroke (Shen, Chen et al. 2010, Chai, Chu et al. 2008). This relationship between acute 
stroke and PEM is very much influenced by patient age, since the highest prevalence of stroke 
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exists in the elderly. The Centers for Disease Control and Prevention (CDC) analyzed data from 
the 2005 Behavioural Risk Factor Surveillance System (BRFSS) survey in a sample of 356,112 
people across the United States and reported that 8.1% of respondents aged over 65 years 
reported a history of stroke, compared with 0.8% of persons aged 18-44 years (Centers for 
Disease Control and Prevention (CDC) 2007). The risk of PEM also increases with increasing 
age. Because of their reduced reserves and diminished food intake (Gariballa, Parker et al. 
1998b), elderly patients are more prone to being malnourished even if they do not present with 
any illness (Manandhar 1995). Development of illnesses, which are common in this age group, 
is another risk factor for the progression of malnutrition (Mowe, Bohmer et al. 1994). 
Upon admission to a hospital for acute stroke, it was estimated in the 1990’s that at 
least 16% of elderly patients were already malnourished (Gariballa, Parker et al. 1998b, Davalos, 
Ricart et al. 1996). Recent studies show that the statistics have not improved (Shen, Chen et al. 
2011, Yang, Wang et al. 2009, Davis, Wong et al. 2004). In Taiwan, a study assessed the 
functional outcome of stroke patients related to their nutritional status, and showed that 19.7% 
were malnourished at admission (Shen, Chen et al. 2010). One study provided evidence that 
patients that were malnourished on admission to the hospital had reduced functional ability and 
survival at 6 months after stroke; however, the study design did not allow for testing of a cause 
and effect relationship (FOOD Trial Collaboration 2003). A recent study reported an association 
between malnutrition and poor stroke outcome (Babu, Kaul et al. 2013). However, in this study, 
malnutrition was solely measured as low serum albumin concentrations, which is problematic 
because albumin is not a specific marker of malnutrition. There are numerous limitations with 
the existing clinical research studies that have attempted to link nutritional status with stroke 
outcome. These include the heterogeneity of nutritional assessments and diagnosis and the 
inability to isolate important variables in order to establish if nutritional status directly affects 
stroke outcome (Meijers, van Bokhorst-de van der Schueren et al. 2010, Soeters, Reijven et al. 
2008). There are many variables which cannot be controlled for in the clinical reality. Animal 
studies can overcome this limitation because of highly controlled conditions, in which it is 
possible to study single variables affecting outcome (Soeters, Reijven et al. 2008). One such 
study established that pre-existing PEM can impair cognitive recovery after brain ischemia, but 
this study had the limitation of relying on a global brain ischemia model that does not exactly 
mimick stroke (Bobyn, Corbett et al. 2005). 
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Although pre-existing PEM is an important clinical problem, PEM is even more 
prevalent after and as a result of a stroke. Several studies have shown that nutritional status 
worsens during hospital stays after stroke (Gariballa, Parker et al. 1998b, Axelsson, Asplund et 
al. 1989, Crary, Humphrey et al. 2013). After one or two weeks of hospitalization, 26-35% were 
diagnosed as malnourished (Brynningsen, Damsgaard et al. 2007), and by the time of admission 
to a rehabilitation setting, 35-49% received the same diagnosis (Poels, Brinkman-Zijlker et al. 
2006, Finestone, Greene-Finestone et al. 1995). Little is known about the effects of PEM that 
develops during the recovery period following stroke. The experimental models developed in 
this thesis will make it possible in future to address the hypothesis that deteriorating nutritional 
status that develops because of the stroke interferes with brain reorganization that promotes 
recovery. Section 2.2.4 proposes mechanisms by which this could occur. 
 
2.2.2 Causes of PEM after Stroke 
In 1974, Butterworth (2005) had already highlighted a number of practices which 
contributed to the decline of nutritional status in acute care patients. They persist in the system 
today and include: [1] diffusion of responsibility for patient care; [2] the longer than needed use 
of saline or glucose-based parenteral nutrition; [3] the poor observation and even poorer 
documentation of patients’ dietary intake; and [4] failure to diagnose and treat malnutrition 
(Hogan, Healey et al. 2012). Studies have revealed that hospital routines can lead to insufficient 
nutrient intake (Dupertuis, Kossovsky et al. 2003), and that is proposed to be due to lack of 
training and awareness of hospital staff (Kondrup, Johansen et al. 2002). Patients are often 
prescribed ‘nil by mouth’ without being fed by any other route, and often patients are taken to an 
exam or investigation prior to food being served. Another related problem is the multiple 
episodes of fasting prior to exams. Also, the palatability of the food prepared and served is a 
major issue (Sullivan, Sun et al. 1999, Incalzi, Gemma et al. 1996, Dutta, Josiah et al. 2013). The 
post-stroke patient is particularly vulnerable to developing PEM because of additional feeding 
challenges related to the stroke. 
There are many causes for the development of PEM after stroke, and they involve: 
[1] the patient, [2] the health professionals and the health system, and [3] the acute disease 
(stroke) itself. The greatest reason for post-stroke patients to become malnourished is that they 
often cannot eat by themselves. The reasons are physical or mental incapacities, communication 
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and perception problems (Gariballa, Parker et al. 1998b), and the result is a reduced nutrient 
intake and a consequent malnourished status (Unosson, Ek et al. 1994). Many patients develop 
swallowing problems (dysphagia) which delay nutritional supply after a stroke (Hayes 1998). 
Dysphagia that develops after stroke can also be permanent, in which case alternative feeding 
has to be considered (Coyle 2012). However, the relationship is complex since although early 
tube feeding might reduce fatality in dysphagic stroke patients, it has been shown to increase the 
proportion of those surviving with poor outcome (Dennis, Lewis et al. 2005). Others are 
paralysed on their dominant side of the body, or have taste and smell perceptions altered (Akner, 
Cederholm 2001). There are also those who become depressed or have cognitive changes that 
affect eating behaviours (Richards, Malouin et al. 2009). All of these factors contribute to weight 
and muscle mass loss that will eventually result in PEM. 
Stroke patients do not present with the elevated resting metabolic rate and protein 
requirements that occurs in stress states such as traumatic brain injury; this is an important point 
when analyzing their nutritional requirements (Finestone, Greene-Finestone et al. 2003). 
However, there are other aspects related to stroke that could lead to alterations in caloric and 
protein requirements, such as infection, age, severity of stroke, medications, ventilator status, 
activity levels, mobility and nutritional status prior to the stroke. For the determination of 
nutritional diagnosis and requirements in the stroke patient, it is thus essential to have a complete 
assessment (Corrigan, Escuro et al. 2011). 
 
2.2.3 Diagnosis of PEM – Nutritional Assessment 
The prevalence of PEM developing after stroke varies greatly among published 
studies (22-62%) (Finestone, Greene-Finestone et al. 1995, Axelsson, Asplund et al. 1988, 
Davalos, Ricart et al. 1996, Unosson, Ek et al. 1994, Shen, Chen et al. 2010b, Choi-Kwon, Yang 
et al. 1998). The reason for the differences in prevalence could be patients’ characteristics. 
However, since there is no gold standard for nutritional assessment and no one single definition 
of malnutrition accepted unanimously, the greatest problems with these studies are methodology 
and timing of the assessment. Most studies choose one tool for the nutritional diagnosis and fail 
to perform a comprehensive assessment. Since some sequelae after stroke can mimick signs of 
malnutrition, this obstructs the process of detection, especially if there is only one tool being 
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used for diagnosis (Foley, Salter et al. 2009). However, it is important to note that different 
studies, using different assessments and protocols, still report high, although different, 
prevalence of PEM after stroke. This shows that post-stroke PEM is truly an existing problem. 
The potential consequences of PEM on the outcomes of stroke justify the need for a 
complete nutritional screening of stroke patients upon admission and at regular intervals after the 
stroke. The assessment of nutritional status can be used to support the decisions regarding 
nutritional support and will diminish complications associated with malnutrition (reviewed in 
Green, Watson 2006). Ideally, a multi-parameter assessment should be performed prior to the 
diagnosis, and it should include biochemical, anthropometric, and functional assessments, as 
well as a nutritional history. Screening for malnutrition should be top priority (Gibson 2005) and 
parameters of diagnosis should be well defined. 
 
 2.2.3.1 Nutritional History 
The most important information to collect from the stroke patient is history of 
weight loss. One study showed that weight loss after the age of 50 years is associated with 
increased mortality. Information regarding weight at different times can be compared to present 
weight (Bush, Horenkamp et al. 1996). Evaluation of dietary intake should also be performed, 
since stroke patients tend to consume less than estimated requirements (Ha, Hauge et al. 2010). 
Different techniques can be applied with the objective of reviewing food preferences, number 
and frequency of meals, portions and sizes, ability to prepare food, place of preparation and 
consumption, and presence of other people. There are published studies regarding validity and 
reproducibility of dietary assessment. However, in the stroke patient, dietary assessment alone 
cannot be used in the diagnosis of malnutrition (Nip, Perry et al. 2011). 
 
2.2.3.2 Anthropometric Measurements 
Weight loss is the first identifiable sign of PEM. The simplest and cheapest methods 
to assess body composition are anthropometric measurements and thus they are generally used 
in the diagnosis of malnutrition if appropriate equations are available (Chumlea, Roche et al. 
1984). Anthropometric measurements include weight, height, mid-upper arm circumference and 
skinfold thickness. 
Weight is a fundamental part of anthropometric analysis. It should be obtained with 
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attention to edema, ascites and clothing. Paired with height, weight measurement allows for 
body-mass index calculation (BMI) which is widely used in the assessment of PEM severity. 
The protocol classifies a BMI of ≥ 18.5 kg/m2 as normal, 17-18.4 kg/m2 as mild PEM, 16-16.9 
kg/m2 as moderate PEM, and <16 kg/m2 as severe PEM (World Health Organization 2006). One 
study showed that BMI closely correlates with other sophisticated measurements in estimating 
nutritional status (Blaum, O'Neill et al. 1997). Other nutritional deficits can also cause weight 
loss and muscle wasting, and thus anthropometry cannot be used alone to diagnose PEM. 
Certain 
medical conditions and medications can have an effect on anthropometric measurements and 
therefore reduce sensitivity and specificity of the measurements. Biochemical assessment can be 
used to complement the history and anthropometry in the diagnosis of PEM (Blaum, O'Neill et 
al. 1997). 
 
 2.2.3.3 Biochemical Assessment 
The decrease in protein intake and reduction in skeletal muscle associated with PEM 
can interfere with protein breakdown and synthesis. The result is limited amino acid availability 
and reduced protein synthesis (Torun 2006). The concentrations of certain proteins in the serum 
can be considered markers for the body protein pool and thus are used as diagnostic tools. 
Albumin, transferrin, and retinol-binding protein are examples of serum proteins that can be 
measured. Chronic nutritional changes are better tested by proteins with a long half-life, whereas 
acute settings require proteins with a short half-life (reviewed in Omran, Morley 2000). 
Lymphocyte counts and white blood cell counts are also indicators of PEM (Gibson 2005). It is 
important to note, nonetheless, that since these tools lack specificity, there are limitations to 
using biochemical markers to diagnose PEM. 
 
Serum Albumin 
In the past, serum albumin concentration was a major tool in the diagnosis of PEM, 
whereas its limitations are currently more widely appreciated. Many stroke studies used serum 
albumin as a tool in the diagnosis of PEM (Babu, Kaul et al. 2013, Unosson, Ek et al. 1994, 
Dziedzic, Slowik et al. 2004). Although serum albumin has a number of limitations for assessing 
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protein-energy status, it is of note that it is a good predictor of post-stroke mortality, and thus can 
be used to assess risk (Gillum, Ingram et al. 1994, Gariballa, Parker et al. 1998a). 
The usefulness of serum albumin in diagnosing PEM relies on the fact that protein 
deficiency depresses the ability of the liver to synthesize albumin because of limited substrate. 
Serum albumin concentration reflects hepatic synthesis, plasma distribution and protein loss. 
Around 40% of all protein produced by the liver is released into the bloodstream as albumin. 
However, it is important to account for the poor specificity of assessing serum albumin because it 
shifts location under a stress state. More than 60% of albumin is in the extravascular pool but it is 
mobilized to the intravascular space in conditions such as stress and disease to maintain 
circulating levels (Charlton 1996). 
In PEM, there is a decrease in protein synthesis, and the circulating levels of albumin 
cannot be maintained. An important limitation, however, is that serum albumin can also be 
influenced by the acute-phase reaction, which is characterized by the increased synthesis of  
positive acute-phase proteins and decreased synthesis of negative acute phase 
proteins by the liver in response to the secretion of cytokines by inflammatory cells in response 
to injury (Don, Kaysen 2004). Thus, serum albumin is a nonspecific tool in that reduced 
concentration cannot be solely attributed to dietary amino acid availability (Kirsch, Fhrit et al. 
1968). Serum albumin is a negative acute-phase reactant that is diminished in inflammatory 
conditions. The liver reduces albumin synthesis during inflammation while increasing synthesis 
of positive acute- phase proteins that can perform roles in leukocytosis, clotting and tissue repair 
(Don, Kaysen 2004; Kirsch, Fhrit et al. 1968). In fact, Qu et al. (1996) have demonstrated in a 
rat model that the effects of dietary protein depletion and inflammation on serum albumin levels 
can be similar in degree. 
 
Liver Lipid Content 
Although not a part of conventional nutritional assessment in humans, liver lipid 
content is an indicator of PEM. The liver is very affected in protein-energy malnourished 
individuals. Fatty infiltration of the liver is seen in both humans (Thurnham 1990) and animals 
(Kirsch, Brock et al. 1968) with PEM. Liver steatosis with an increase in triacylglycerol is used 
as a specific indicator of PEM. Rats fed low-protein diets have lipid accumulation in the liver 
possibly because there is an impaired transport of triacylglycerol by very-low-density 
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lipoproteins (VLDL). VLDLs are reduced due to a reduction in the synthesis of VLDL 
apolipoproteins by the liver in the malnourished individual (Seakins, Waterlow 1972, Lamri, 
Meghelli-Bouchenak et al. 1995). 
 
2.2.3.4 Inflammatory Markers 
Recent data suggest that PEM can independently stimulate an acute-phase response 
(Ling, Smith et al. 2004, Smith, Andrade Ramos et al. 2013). Serum inflammatory markers of 
positive and negative acute-phase proteins could be useful in diagnosing and/or characterizing 
PEM. Alpha-1-acid glycoprotein (AGP) is a major positive acute-phase reactant in both humans 
and rats. Although the biological function of AGP is still unknown, studies have shown 
immunomodulating effects and ability to bind and carry certain drugs. Its serum concentration 
increases in response to inflammation, and this elevation is correlated with increased hepatic 
synthesis. Gene expression of AGP is controlled by glucocorticoids and certain cytokines such 
as tumor necrosis factor-α and interleukin-6 (reviewed in Fournier, Medjoubi-N et al. 2000). One 
study suggested a low-grade systemic inflammatory response to PEM on the basis of increased 
serum levels of AGP and the cytokines, tumor necrosis factor-α and interleukin-1β (Ling, Smith 
et al. 2004). 
Another positive acute-phase reactant that can be measured in serum is alpha-2- 
macroglobulin (A2M). The synthesis of this protein is stimulated by cytokines of the interleukin- 
6 family. A2M is responsible for the transport of cellular growth factors and it modulates 
immunological response by inhibiting the activity of natural killer cells and reducing the 
antibody-dependent cell-mediated cytotoxicity (reviewed in Jura, Koj 2011). One study 
demonstrated elevated serum A2M levels and interleukin-6 messenger ribonucleic acid (mRNA) 
in peripheral blood mononuclear cells and intestine of severely protein-malnourished rats 
(Lyoumi, Tamion et al. 1998). 
 
2.2.3.5 Functional Assessments 
PEM causes decrease in muscle strength, poor wound healing, depression, and 
excessive tiredness, all of which are considered functional abnormalities. For a complete 
nutritional assessment and a well-defined nutritional diagnosis, the use of parameters to assess 
function is an asset. Some practices use examinations such as the hand-grip test that allows for 
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strength evaluation and an estimation of muscle loss. However, in the stroke patient, it is difficult 
to define with the hand-grip test if strength is related to a motor deficit caused by stroke or if 
PEM is a contributor (Ha, Hauge et al. 2010). Psychological screening, as well as a thorough 
wound observation are other tools that aid PEM diagnosis (Gibson 2005). 
The problem with functional assessments is the lack of standardization and the 
fact that other deficits can alter function. If used in combination with anthropometry, 
biochemistry and history, however, the functional assessment can assist the diagnosis of PEM. 
 
2.2.4 Proposed Mechanisms by which PEM Could Affect Brain Plasticity and Functional 
Outcome after Stroke 
There is a correlation between nutritional status and outcome after stroke. Stroke 
patients diagnosed as protein-energy malnourished appear to have an increased risk for 
disability and mortality (Gariballa, Parker et al. 1998a, Davalos, Ricart et al. 1996). However, 
the clinical studies have placed more focus on the general health outcomes of PEM, such as 
infection rates, motivation for rehabilitation and development of pressure sores. For example, 
Davalos and colleagues (1996) associated malnutrition, after 1 month of stroke onset, with 
greater incidence of infection and pressure sores, and increased risk of death. While such 
outcomes could clearly be important determinants of patient recovery, the potential for PEM to 
directly influence brain remodelling after stroke is not as well appreciated. 
Despite the fact that the mechanisms by which post-stroke PEM could influence 
recovery have not been extensively explored, the experimental data suggest that there could be 
direct effects on neuroplasticity. PEM in adult rats has been reported to reduce expression of the 
neurotrophin, brain-derived neurotrophic factor (BDNF) and its major receptor, tropomyosin- 
related kinase B (trkB), in surviving neurons (Mesquita, Pereira et al. 2002); these molecules are 
believed to be important  in cell survival, proliferation, differentiation and plasticity in the 
nervous system (Hennigan, O'Callaghan et al. 2007). Also, brain-derived neurotrophic factor is 
increased by environmental enrichment and rehabilitation exercise after stroke. This increase in 
BDNF contributes to the benefit of rehabilitation in promoting recovery after stroke (Maclellan, 
Keough et al. 2011). Recent research from my laboratory showed that PEM beginning 3 days 
after global ischemia (widespread forebrain ischemia), decreased the ischemia- induced increase 
in protein expression of synaptophysin and growth-associated protein 43 (GAP- 43), two 
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plasticity-related proteins, in the cornu ammonis 3 (CA3) region of the hippocampus (Smith, 
2013 unpublished observations). However there have been no studies of this in preclinical rat 
models that better mimick stroke. A second study from my laboratory demonstrated a different 
pattern of alteration in key plasticity proteins when PEM pre-existed with the onset of global 
brain ischemia, providing additional evidence that protein-energy status has the potential to alter 
post-stroke plasticity (Prosser-Loose, Verge et al. 2010). However neither of these studies 
attempted to relate the alterations in these proteins to functional outcome. 
Neurogenesis, which is another type of plasticity, could also be affected by PEM. 
Several studies have linked diet to the modulation of adult neurogenesis in the hippocampus 
(reviewed in Zainuddin, Thuret 2012), but exact mechanisms have yet to be described. One may 
be alteration of release of growth factors, which are thought to be involved in neural sprouting 
and endogenous progenitor cell migration and differentiation in the brain (Cairns, Finklestein 
2003). Some growth factors are decreased in the serum because of poor nutritional status (Alves, 
Torrinhas et al. 2012). Malnutrition has been shown to decrease, for example, insulin growth- 
factor 1 (IGF-1) in the serum of neonatal rats (Donovan, Atilano et al. 1991).  Insulin growth- 
factor 1 is an anti-apoptotic factor, and has been shown to play a role in promotion of 
proliferation and differentiation of neuronal progenitors (reviewed in Kriz, Lalancette-Habert 
2009). 
Brain inflammation after stroke appears to exert an important influence on 
neuroplasticity; whether inflammation is beneficial or deleterious to the ischemic brain is still 
controversial (Kriz, Lalancette-Habert 2009). Reports from my laboratory have been inconsistent 
as to whether PEM increases brain inflammation following cerebral ischemia (Bobyn, Corbett et 
al. 2005, Prosser-Loose, Smith et al. 2011, Ji, Nazarali et al. 2008, Smith, Prosser-Loose et al. 
2011). Additional limitations are that these studies are restricted to analysing the influence of 
pre-existing PEM on global ischemia, but not stroke. However, more recently, we have 
demonstrated that PEM causes an acute phase response, which may be indicative of a systemic 
inflammatory stimulus (Smith, Andrade Ramos et al. 2013; Smith, 2013 unpublished 
observations). This may be important to the malnourished stroke patient, since increased levels 
of acute-phase proteins are associated with poor outcome after stroke (Whiteley, Jackson et al. 
2009). 
This thesis research is based on the underlying hypothesis that deteriorating protein- 
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energy nutritional status that develops after and because of the stroke interferes with brain 
reorganization, repair and recovery. Well-characterized experimental models of stroke and PEM 
need to be developed in order to test this hypothesis, and are thus the subject of this thesis. 
  
2.3 Experimental Models to Study Post-Stroke PEM 
Animal models would have advantages for investigating whether post-stroke PEM 
affects neuroplasticity while avoiding ethical barriers associated with human investigation and 
exerting the strict study control that has not been achieved in the clinical studies to date. The 
study of mechanistic effects, co-morbidity factors, and novel therapies is not only possible, but a 
common baseline undertaken before clinical trials. The development of such animal models is 
the object of this thesis research. 
 
2.3.1 Stroke Models 
Modeling human disorders in experimental animals allows for a better understanding 
of mechanisms and provides the basis for the development of current and novel treatments 
(Lieschke, Currie 2007). The advantage of using a cerebral ischemia model is to understand the 
various mechanisms of injury, and later find potential sites for neuroprotection or enhance 
understanding of neuroplastic mechanisms that underlie rehabilitation strategies. Several criteria 
should be considered when using an animal stroke model: (1) the pathophysiology should 
resemble that of human ischemic stroke; (2) the procedure should be non-invasive and 
physiological variables monitored and kept within normal range; (3) the lesion should be 
reproducible; and (4) histological and functional assessments are to be used in the evaluation of 
stroke severity (Traystman 2003). There is international consensus on how these models should 
be run to be reliable. The Stroke Therapy Academic Industry Roundtable (STAIR) published 
recommendations to improve the quality of stroke studies, and they include: (1) using a well- 
characterized model and long survival times to ensure reliability and test the permanence of any 
protective effects; (2) including comorbidity factors along with stroke, to better mimick the 
clinical reality, and (3) run studies in older animals, to both mimick the clinical situation and see 
the effects of age (Albers, Goldstein et al. 2011). These recommendations were made because 
the majority of animal stroke studies have been done in adolescent animals, and many of these 
suffer from poor control of physiological variables, short survival times and the absence of 
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functional assessments. 
There are many models available, all of which reduce glucose and oxygen supply to 
the brain, producing ischemic injury by impairing the energy necessary to maintain normal 
functioning of the brain (Traystman 2003).  The rat is the animal most commonly used in stroke 
studies. There is homology in both behaviour and anatomy between humans and rodents, and 
this renders the rat as an excellent animal for neurological studies (Cenci, Whishaw et al. 2002). 
However, rats lack gyrencephalic brains, which makes them different than humans in behaviour 
and sensorimotor integration (Uylings, Van Eden 1991). In the rat, it is possible to monitor 
physiological variables. Rats have homogeneity within strains, and have relatively low cost of 
care and availability, which are other positive factors to consider when choosing animals as 
models of human disease (Lieschke, Currie 2007, Bacigaluppi, Comi et al. 2010). 
Brain ischemia models are categorized as focal or global ischemia on the basis of 
location of the ischemia. Global ischemia models best mimick brain damage caused by cardiac 
arrest, and occur when blood flow to the brain is reduced in most or all of the tissue. Focal 
ischemia models more closely mimick ischemic stroke, and thus are the subject of this thesis; the 
reduction in blood flow is restricted to a specific part of the brain (Bacigaluppi, Comi et al. 
2010). Models can be further classified as transient or permanent occlusion. In transient 
occlusion models, there is reperfusion, whereas in permanent occlusion models, there is no- 
reflow following. Without reperfusion, there is incomplete restoration of blood flow and the 
result is fewer surviving neurons (reviewed in Doyle, Simon et al. 2008). 
 
2.3.1.1 Focal Ischemia Models 
There are many models of focal ischemia, and most of them involve occlusion of 
one major cerebral blood vessel. The middle cerebral artery occlusion (MCAO) is the most 
common 
(Hossmann 1991). The result of this occlusion is the reduction in blood flow to the 
cortex. Whether the brain injury also extends beyond the cortex to the striatum depends on the 
duration of occlusion, the site of occlusion and the amount of blood flow collateral to the 
occlusion area. These models are intended to resemble human thromboembolic stroke (Garcia 
1984). 
The major rat focal ischemia models can be classified as the: [1] endothelin 1 
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vasoconstriction model, [2] MCAO (proximal or distal) model, [3] intraluminal suture model, [4] 
middle cerebral artery embolism, and [5] photothrombotic model (Murphy, Corbett 2009). 
[1] Endothelin 1 vasoconstriction 
Endothelin is an endogenous peptide that causes vasoconstriction, and when it is 
applied to the middle cerebral artery (MCA), cerebral blood flow decreases in that territory, 
causing an ischemic lesion (Windle, Szymanska et al. 2006). This has been reported to yield 
considerable variability among different laboratories, which is a disadvantage of the model. 
[2] Proximal or distal MCAO 
Different surgical methods can be used to promote MCAO. Cauterization results in 
permanent occlusion, and clipping or snares allow for reperfusion. Variations include the 
occlusion of different arteries. A disadvantage is the invasiveness of the procedures and the need 
for good surgical skills (Murphy, Corbett 2009). 
[3] Intraluminal suture model 
In this model, occlusion is produced by inserting a suture into the internal carotid 
artery to block blood flow to the MCA, by transection of the external carotid artery. It is a 
technique suitable for neuroprotective drug experiments, because it produces a good penumbra. 
The suture can also be withdrawn to allow studies of the aspects of reperfusion. However, 
subarachnoid haemorrhage secondary to suture-induced arterial rupture is likely to happen. The 
endothelium can also be damaged, which complicates reperfusion, and the procedure affects 
muscles related to mastication and swallowing, leading to a decrease in food intake and weight 
loss (Bederson, Pitts et al. 1986). The biggest problem with this model, and the reason why 
many laboratories have rejected this technique, is that it often causes hypothalamic injury 
together with the stroke. This can complicate histological and behavioural outcomes because 
motivation and temperature regulation also change. Also, extensive damage such as the one 
produced by this model normally causes death or untreatable infarcts in human stroke, which 
renders the model unsuitable for studying the treatable stroke patient (reviewed in Murphy, 
Corbett 2009). 
[4] Middle cerebral artery embolism 
This model requires the introduction of a blood clot, via the internal carotid artery, to 
occlude the MCA. It mimicks human ischemic stroke very well because the stroke tends to be 
smaller than those produced by other models. A limitation is that there is high variability and 
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mortality associated with this model since the clots can undergo spontaneous thrombolysis and 
cause multiple infarcts (Murphy, Corbett 2009). 
[5] Photothrombotic model 
With this model, which has been chosen for the thesis research, a cortical infarct is 
induced by injection of a photoactive dye that is irradiated by a light beam transmitted through 
the skull. There is oxidative damage to the endothelium caused by the altered dye, which leads 
to platelet aggregation in the irradiated areas. It is a less surgically invasive procedure that 
results in reproducible infarcts that can be targeted to any cortical location (Murphy, Corbett 
2009). A detailed discussion of the photothrombotic stroke model is found in Chapter 4. 
 
2.3.1.2 Sensorimotor Cortex 
Rat stroke models, including the photothrombotic model, often have the goal of 
inducing injury in the sensorimotor cortex, and thus a brief anatomical review is included here. 
Sensorimotor deficits in the rat after stroke display many similarities with those in humans who 
are left with motor impairments after stroke (Cenci, Whishaw et al. 2002). Depending on the 
type of stroke, patients may present with altered functional abilities that include loss of 
mobility, manual disability, psychomotor and cognitive function, and paralysis (Chen, Rimmer 
2011). 
The photothrombotic stroke model can be used to produce infarction in preselected 
cortical regions, which facilitates the analysis of functional, as well as structural consequences of 
acute stroke. Impairments in skilled and gross motor performance are enduring disabilities after 
stroke in primate and non-primate animals (Wolf, Catlin et al. 2001). The motor abnormalities 
after stroke are associated with damage to cortical (e.g. motor cortex) and subcortical areas (e.g. 
basal ganglia, the caudate nucleus) involved in control and execution of motor performance. The 
neural organization of the motor system is similar in rats and primates. As defined through 
electrophysiological mapping, the rat has two forelimb regions in its motor cortex that may be 
homologous to the primary and supplementary motor cortex of primates (Kleim, Barbay et al. 
1998). Therefore, rodent model systems are created and used to study stroke associated motor 
abnormalities. Well-validated models of stroke in the rat induce ischemia in the forelimb and/or 
hindlimb regions of the cortex (Ploughman, Windle et al. 2009, Boyko, Zlotnik et al. 2010). 
Functional tests such as the ladder test, cylinder test, Montoya staircase test, and single pellet 
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reach test are used to measure the deficits observed in both skilled and gross motor performance 
(Jackson 2009). 
In the earliest study of cortical control of skilled reaching, Peterson and Francarol 
(1951) delineated the region of the cortex in which stroke produced a change in paw preference 
previously established by training. They found that the most effective region for producing a 
change in handedness is the motor cortex. The photothrombotic model of focal ischemia in rats, 
as used in our studies, can promote occlusion of the distal part of the middle cerebral artery 
(MCA) and arterioles supplying cortical areas involved in skilled motor behavior (Moon, 
Alaverdashvili et al. 2009, Metz, Whishaw 2009, Alaverdashvili, Moon et al. 2008). 
Motor representations in rats have been localized by surface and intracortical 
stimulation of the cortex. Parcellation of primary motor and sensory cortices is relatively 
challenging in rats because of the overlap of sensory and motor areas. Nevertheless, 
juxtaposition of the findings from histological and electrophysiological studies revealed that 
frontal cortical areas that (1) lack a distinct granular layer IV i.e. an agranular area (Kreig 1946) 
and (2) require low microstimulation currents to elicit movement corresponds to primary motor 
cortex. Primary motor cortex is localized mainly in the lateral agranular field. Nevertheless, 
there is a part of the motor cortex that overlaps with sensory cortex that lies in the medial 
agranular field that requires high microstimulation currents to evoke movements. Therefore, this 
area has not been considered as primary motor cortex. The majority of the motor cortex 
topographic representation is employed by areas that stimulate movement of hindlimb, forelimb, 
jaw, lips and tongue (Kolb, Wishaw 1983). 
Rat motor cortex receives afferents from cortical somatosensory areas, cortical and 
subcortical motor control structures and some subcortical nuclei. It sends the efferents to the 
spinal cord, brain stem and red nucleus, the regions in the central nervous system that directly 
control muscle activity (Donoghue, Wise 1982). 
The deficit in skilled upper extremity functions is the most severe and enduring 
motor abnormality after stroke (Richards, Malouin et al. 2009, Hoffman, Strick 1995). In this 
research thesis, the photothrombotic model of focal ischemia was thus used to target the cortical 
region involved in forelimb function as a means of mimicking the human condition. 
Two discontinuous forelimb regions have been identified in rat motor cortex 
(Neafsey, Sievert 1982) [1] a large caudal area that begins at bregma; and [2] a small rostral 
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area, near the frontal pole. The small rostral area is located in the lateral agranular field region, 
whereas the large caudal area lies both in the lateral agranular field and the sensory cortex 
(Neafsey, Sievert 1982). 
There is not very clear separation on different parts of hand segments in rostral vs. 
caudal forelimb areas (Lemon, Griffiths 2005). Differences in movements are observed when 
each area is targeted. When the caudal area is stimulated, wrist, elbow, or shoulder is targeted. 
When the rostral zone is stimulated, digit movement as well as elbow movements are elicited. 
Within the rostral zone, digit movements are evoked more laterally while elbow movements 
are seen medially (Neafsey, Bold et al. 1986). 
 
2.3.1.3 Assessment of Brain Injury 
Stroke, as well as neuroplasticity, alters the brain morphologically as well as 
functionally. A complete assessment of motor alterations, in addition to observation of anatomic 
changes, is necessary to accurately assess reliability and consistency of the alterations and extent 
of brain injury. 
 
Histology 
The main objective in using histology to assess ischemic injury in experimental 
models of stroke is to localize and measure infarct volume. Several stains are used to identify 
the infarct after stroke, including hematoxylin and eosin staining, nitroblue tetrazolium, and 
Nissl staining (reviewed in Tatlisumak, Li et al. 2007). Nissl staining (cresyl violet) is 
commonly used in stroke studies because the Nissl granule is found in neurons. These granules 
are rough endoplasmic reticulum and they are stained in the cresyl violet method because 
neuronal cytoplasm has acidic components (such as extranuclear RNA granules) that bind to the 
basic stain (Alvarez-Buylla, Ling et al. 1990). Cresyl violet does not specifically stain neurons 
but the high concentration of Nissl substance in neurons gives its blue characteristic color 
(Türeyen, Vemuganti et al. 2004). Nissl bodies change in pathological conditions and cell death. 
Neurons after stroke can appear shrunken at early time-points. Longer time-points will show 
diminished cresyl violet staining in the infarct area, because of chromatolysis (Türeyen, 
Vemuganti et al. 2004). 
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Behavioural Assessment 
It is essential to compare histological results with functional (behavioural) endpoints 
since neurons exposed to ischemia can appear normal on histological analysis but have abnormal 
function. A number of behavioural tests can be used to assess functional recovery after focal 
ischemia. Two well-characterized tests, the Montoya staircase and the cylinder task, were chosen 
for evaluation of functional impairments and recovery for this thesis research. 
The task developed by Montoya et al (1991) can provide a complex objective 
assessment of the functional deficit caused by cortical ischemia in the rat. It provides a 
measurement of skilled forepaw use, and reaching and grasping abilities can be measured 
quantitatively. The Montoya apparatus consists of a rectangular Plexiglas box in which the 
animal is positioned in a central platform. On each side of the platform, there is a 7 step staircase, 
each with a well to hold sugar pellets. The presentation of pellets gives the rat 7 degrees of 
reaching difficulty; the lower the step, the harder it is for the animal to retrieve pellets. This task 
provides an objective measure of side bias, forelimb extension and grasping ability (Montoya, 
Campbell-Hope et al. 1991). 
Numerous studies have validated the use of this task for different strains of rats 
(Pagnussat, Michaelsen et al. 2009, Webb, Gowribai et al. 2003, Colbourne, Corbett et al. 2000, 
MacLellan, Gyawali et al. 2006, Klein, Sacrey et al. 2012). Advantages of using this task to 
assess functional deficits of the forelimbs are the simplicity of the method and the low rate of 
animal exclusion due to inability to train, since most animals are able to reach the minimum 
criteria (Montoya, Campbell-Hope et al. 1991). After stroke, rats are expected to greatly decrease 
the number of pellets eaten because they are unable to reach from the affected side (contralateral 
to that of stroke placement) (Ploughman, Windle et al. 2009). Functional deficits depend on 
severity of stroke, localization and type of infarct, day of post-stroke testing and the overall 
condition of the animals (e.g. stress, wound healing). Functional recovery is also expected after 
stroke in the rat, and typically progresses over time. Very small lesions result in full functional 
recovery of the affected limb. Medium to large lesions will result in improvements in reaching 
ability but not full recovery (Moon, Alaverdashvili et al. 2009, Soleman, Yip et al. 2010, 
Rasmussen, Overgaard et al. 2011). Some authors have also noted that animals can become more 
proficient after stroke at using the ipsilateral (unaffected) paw to retrieve pellets (Grabowski, 
Brundin et al. 1993). The number of trials after stroke will dictate whether the task works as a 
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functional test or a rehabilitative therapy, since the Montoya staircase test can have beneficial 
effects on early rehabilitation, affecting neuroplasticity and functional recovery (Clarke, Mala et 
al. 2009). 
The cylinder test involves a Plexiglas cylinder that is wide enough for the rat to 
vertically explore. Animals rear and touch the walls of the cylinder by using one or both paws 
for postural support. Preferred paw use for support can be observed by analyzing video 
recordings taped from below via an angled mirror (Gharbawie, Whishaw et al. 2004). After 
stroke, rats are expected to decrease the number of wall touches with the affected paw 
(Minnerup, Kim et al. 2011, Milgram 2002). One group was able to distinguish differences in 
the cylinder test between rats exposed to sham surgery and stroke for up to one month 
(Schallert, Fleming et al. 2000). Various recent studies have used the cylinder test to assess 
motor recovery after ischemic stroke in the rat (Minnerup, Kim et al. 2011, Ploughman, Windle 
et al. 2009, Diederich, Frauenknecht et al. 2012, Yanev, Jolkkonen et al. 2010, Diederich, 
Quennet et al. 2012). 
 
2.3.2 Protein-Energy Malnutrition Models in the Rat 
Although there are no established standards for modelling PEM in rats, there is 
extensive literature describing models of PEM in rapidly growing weanling and adolescent rats 
(Heard, Frangi et al. 1977, de Belchior, Aucelia C. S., Angeli et al. 2012, Lago, Teodosio et al. 
1993). However, there is little information regarding such models in the adult rat. It is important 
to develop this model to mimick PEM arising after stroke. Factors such as diet formulation, 
severity of malnutrition and whether the aim is acute or chronic malnutrition need to be taken 
into consideration in the model development. The parameters to diagnose PEM in the rat should 
include body weight, food intake, biochemical markers of malnutrition, such as liver lipid 
content and serum albumin concentration. The rationale and the details for the development of 
the PEM model in adult rats to mimick the acutely malnourished stroke patient are discussed in 
Chapter 3. 
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CHAPTER 3 
MODELLING POST-STROKE PROTEIN-ENERGY MALNUTRITION 
 
3.1 Introduction 
PEM commonly arises following stroke. Although prevalence estimates show some 
variability, partly related to methodological limitations, up to 35-49% of stroke patients are 
believed to be affected (Finestone, Greene-Finestone et al. 1995, Poels, Brinkman-Zijlker et al. 
2006). Many factors contribute to weight and muscle mass loss after stroke. These are related to 
age, eating difficulties, delayed nutritional supply and motor impairments that affect eating 
habits. The older population is more prone to the development of malnutrition after stroke 
(Mowe, Bohmer et al. 1994) because of their reduced reserves and diminished food intake 
(Gariballa, Parker et al. 1998b). Often, stroke patients cannot eat by themselves due to both 
physical and mental disabilities. The need to be fed greatly increases the risk for the development 
of malnutrition (Gariballa, Parker et al. 1998b). Swallowing problems after brain infarction delay 
nutritional supply until a medical assessment authorizes alternative feeding routes (Hayes 1998). 
Even after tube feeding has been prescribed, patients are frequently left in a fasted state for long 
periods due to shortage of staff or lack of proper training (Mould 2009, Unosson, Ek et al. 1994). 
Some patients suffer paralysis on the dominant side of the body or have altered taste and smell 
perceptions (Akner, Cederholm 2001). There are also those who become depressed or have 
cognitive changes that affect eating behaviours (Richards, Malouin et al. 2009). 
Clinical data have shown poor nutritional status to be associated with poor survival 
and functional outcome following stroke (Shen, Chen et al. 2010, Chai, Chu et al. 2008). 
However, these studies have not been designed to examine if there is a direct causal relationship, 
which reinforces the need for experimental studies to address this question. The exact 
mechanisms by which PEM could affect brain plasticity and remodelling are similarly not 
understood. Such questions could be investigated by combining an adult rat model of stroke with 
acute, moderate PEM that mimicks what occurs in patients after stroke (Shen, Chen et al. 2011, 
Nip, Perry et al. 2011). 
Well-established methods exist for inducing PEM in young, rapidly growing 
weanling and adolescent rats. These rely on feeding diets of low protein composition (0.5-5%) 
that cause an accompanying voluntary reduction in food intake, resulting in moderate to severe 
PEM (Swenne, Borg et al. 1992, Coward, Whitehead et al. 1977, Ling, Smith et al. 2004, Taylor, 
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Bauman et al. 1992, Prosser-Loose, Smith et al. 2011). Data also exist for inducing PEM in aged 
rats that have a lower protein requirement. One study compared protein needs of 15 and 25 
month-old rats and reported that both groups were still gaining weight when fed a 2% protein 
diet for 21 days (Fischer, Canolty 1983). However, there is limited information on models to 
generate different types of PEM in the adult rat. Since developing a model of PEM depends on 
the energy and protein requirements for the age and sex of rat under study as well as diet 
composition (Woodward 1998, Reeves, Nielsen et al. 1993), the first objective of this study was 
to develop a dietary PEM model for the adult rat. 
One challenge is to estimate protein requirement for the 16-20 week old adult rat to 
be used in our studies. Protein requirements are influenced by age and growth rate (Lewis, Ullrey 
et al. 2006), and protein requirements decrease with age until rats reach about 1 year of age 
(Hartsook, Mitchell 1956). For instance, a protein restriction of 5% will induce PEM in 8 week 
old but not 24 week old rats (Kahn, Bender 1979). Twelve % protein is the level at which 
nitrogen balance is maintained at 10 weeks of age (Archer, Vernon Rayner et al. 2003). 
However, 10 week old rats have a higher growth rate and protein requirement than the 16 week 
old rats to be used in our studies, for which 4-6% protein is believed to maintain nitrogen balance 
(Levin, Keesey 1998). The energy concentration of the diet and the source and quality of protein, 
which influence the biological availability of the amino acids, also influence protein 
requirements (Lewis, Ullrey et al. 2006). The National Research Council guidelines suggest that 
for adult rats, if high-quality protein is used, protein requirement is 5% of total energy intake, 
whereas when the diet is made of poor-quality proteins, requirement increases to 7% of total 
intake (National Research Council 1995). 
Another important consideration when modeling PEM is whether acute or chronic 
malnutrition is the goal. Acute PEM in humans causes faster weight loss and a more dramatic 
change in the biochemical markers of malnutrition, such as serum albumin concentration, than 
does chronic PEM. After stroke, human patients suffer a rapid drop in weight, of about 2-4% in 2 
weeks, which results in an acute state of mild-moderate PEM (Shen, Chen et al. 2011, Unosson, 
Ek et al. 1994, Jönsson, Lindgren et al. 2008). After 1 month of stroke onset, the range is 2-11% 
loss of body weight (Jönsson, Lindgren et al. 2008, Gariballa, Parker et al. 1998b, Finestone, 
Greene-Finestone et al. 1995). To achieve acute PEM in rats, the protein content of the diet has to 
be lower than that used to induce chronic PEM. Based on the available literature, it was 
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hypothesized that a American Institute of Nutrition 1993 Maintenance diet (AIN-93M diet) 
(Reeves, Nielsen et al. 1993) modified to contain either 1% or 0.5% protein of high biological 
value would produce an acute state of mild-moderate PEM in adult rats, and that the diet 
containing 0.5% protein would have the more rapid effects. We predicted that both diets would be 
accompanied by a voluntary reduction in total food, and thus energy, intake. The PEM was 
characterized on the basis of food intake, body weight, serum acute phase protein concentrations, 
and liver lipid content. 
In characterizing the PEM, a second objective of the study was to investigate the 
extent to which an acute phase response is induced, since systemic inflammation may worsen 
stroke outcome (Vila, Filella et al. 1999, McColl, Rothwell et al. 2008). This was assessed on the 
basis of serum concentrations of two positive acute phase proteins, alpha-1-acid glycoprotein 
(Fournier, Medjoubi-N et al. 2000) and alpha-2 macroglobulin (Gauthier, Mouray 1976), and the 
negative acute phase reactant, serum albumin (Don, Kaysen 2004). Ling et al. (2004) have 
reported increased inflammatory markers such as interleukin-6, interleukin-1 and tumor necrosis 
factor-alpha in the serum of young malnourished rats. Another group showed that PEM in 6 
week-old rats increases a positive acute-phase protein, serum alpha-2 macroglobulin (Lyoumi, 
Tamion et al. 1998). Our laboratory has previously measured elevated serum alpha-2 
macroglobulin concentrations in protein-energy malnourished adolescent rats (Smith, Andrade 
Ramos et al. 2013). In humans, serum analysis of protein-energy malnourished children showed 
increased interleukin-6 concentration (Dulger, Arik et al. 2002). Additionally, serum albumin 
concentration, which often rapidly declines with PEM, can provide evidence for an inflammatory 
stimulus. Serum albumin is a major negative acute-phase protein (Don, Kaysen 2004), but is also 
influenced by decreased dietary amino acid supply for synthesis, preventing its use as a specific 
marker of inflammation (Qu, Ling et al. 1996; Omran, Morley 2000). One study in rats showed 
that the effect of protein depletion and inflammation on serum albumin levels can be similar in 
degree (Qu, Ling et al. 1996). 
Motor disabilities are among the various impairments that occur after stroke. 
Functional alterations caused by paralysis are very common and can last a lifetime (Kreisel, 
Hennerici et al. 2007). Whether post-stroke PEM worsens these motor impairments is unknown 
and should be addressed in a rat pre-clinical stroke model. Among behavioural tests used to 
assess functional impairment and recovery in rat stroke models, the well-validated Montoya 
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staircase is sensitive for detecting motor deficits (Montoya, Campbell-Hope et al. 1991, 
Pagnussat, Michaelsen et al. 2009, Rasmussen, Overgaard et al. 2011, Clarke, Mala et al. 2009). 
The task developed by Montoya et al (1991) measures skilled forepaw use by assessing the 
ability to reach and grasp for a desirable food such as sugar pellets. The third study objective was 
to test whether the development of PEM in the adult rat independently causes any motor 
alterations in this task, which could confound future use of the test for assessing the effect of 
nutritional status on post-stroke motor deficits. 
The final objective was to further validate the Montoya staircase for use in protein- 
energy malnourished rats, by testing whether rats sustained motivation to obtain sugar pellets as 
PEM developed. An imbalance in the protein/carbohydrate ratio, as is the case with a low protein 
diet, is known to affect the amount and type of foods that a rat chooses to eat (Theall, Wurtman 
et al. 1984). For instance, if fed below protein requirement, the rat will voluntarily decrease 
carbohydrate intake, when given the choice, in order to re-establish the normal 
protein/carbohydrate ratio (Li, Anderson 1982, Anderson 1979). Thus, we assessed whether a 
low protein diet and the development of PEM over 31 days would render rats less motivated to 
reach for sugar pellets. 
 
3.2 Materials and Methods 
3.2.1 Experimental Design 
Adult, male, Sprague-Dawley rats, 13 weeks old (N=26) were caged in groups of 2. 
Housing facilities were maintained at 22°C and had a 12hr light/dark cycle. Rats were 
acclimatized to the facility for 3 days with ad libitum access to control diet (see details below) 
and water. On the fourth day, animals were removed from the colony to the behavioral room 
where they were acclimated for 30 minutes in their cages. After that time, they were handled for 
10 minutes each. Daily handling was done for 1 week, during which the rats were also weighed 
daily to allow them to acclimate to the procedure. Food intake on a cage basis was measured to 
permit calculation of the food restriction required for the Montoya staircase training period. 
Over the next 15 days, they were exposed to training in the Montoya staircase 2 times/day. On 
the following day, rats were randomized to 1 of 3 diet groups for 31 days: 0.5% protein (n=8), 
1% protein (n=8) or control diet (n=10). 
To assess if diet affected sensorimotor function, the rats were tested in the Montoya 
staircase test on days 3, 15 and 30 post-diet assignment. The test to assess motivation to eat sugar 
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pellets was done on days 2, 14, and 29. During this period, body weight was recorded 2 
times/week and food intake daily. On day 31, rats were humanely euthanized. Blood and liver 
samples were collected for biochemical analysis to assess protein-energy status. The details of 
each step of the experimental design are provided below.This work was approved by the 
University of Saskatchewan’s Animal Research Ethics Board and adhered to the Canadian 
Council on Animal Care guidelines for humane animal use. 
 
3.2.2 Training in the Montoya Staircase 
This task assesses skilled reaching and grasping abilities (Montoya, Campbell-Hope 
et al. 1991). All training for the Montoya staircase test was done during the dark phase with three 
40 watt red lamps, since this is the rat’s active period. All rats were food restricted by 15% 
during the first week of training and 10% during the second week of training to provide 
sufficient motivation to reach for the 45 mg banana flavored sucrose pellets (TestDiet, 
Richmond, IN). 
Before starting the task, the rats were allowed to acclimate in the behaviour room for 
30 minutes. The Montoya box was modified to accommodate the adult rats used in this 
experiment and had 3 adjustable heights for rats of varying sizes (Langdon, Clarke et al. 
2011).This task consists of placing the rat into the box, on top of a central platform that has a 
staircase on either side. Each step of the 7-step staircase has a well that holds 3 sugar pellets. The 
stair arrangement and the platform on which the rats are positioned do not allow the rat to 
retrieve dropped pellets, and the animal is only able to reach for the right steps with the right paw 
and for the left steps with the left paw (Biernaskie, Chernenko et al. 2004). Training consisted of 
15 days, during which the rat was left in the chamber for 15 minutes and the total number of 
pellets eaten, dropped and remaining on the steps was recorded. This procedure was repeated 
after 2 hours; that is, each rat was trained 2 times per day. In between sessions, the rat remained 
in the testing room, in the dark. The number of pellets eaten per side was used as a measure of 
forelimb reaching ability (Montoya, Campbell-Hope et al. 1991). Between individual rat 
sessions, the boxes were cleaned with 70% ethanol and wiped dry with a paper towel. 
Baseline performance in the Montoya staircase was collected on the night before 
assignment to experimental diets at the end of the training period, under the same conditions as 
used for training days. Animals were tested twice for 15 minutes each, and the interval between 
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trials was of at least 2 hours. Only rats that were able to eat with one forepaw 12/21 pellets with 
a standard deviation of ≤ 2 over a period of 8 trials were included in the Montoya staircase 
testing period. Rats that did not meet these criteria were assigned to an experimental diet group 
and used for all other assessments except the Montoya test. After baseline assessment, paw 
preference was determined as the side in which the rat retrieved more pellets. All analysis was 
done with the preferred paw. 
 
3.2.3 Motivation for Performance in the Montoya Staircase 
To evaluate test validity, a motivation test was performed on the night before 
assignment to experimental diets to determine baseline motivation to retrieve sucrose pellets. 
Drive to eat banana-flavored sugar pellets was determined by placing the rat into a standard size 
rat cage (35cm X 25cm X 24 cm) that contained sucrose pellets and timing how fast the pellets 
were eaten (Baunez, Amalric et al. 2002). The 10 sucrose pellets were scattered randomly in the 
cage; the rat was then placed in the cage, the lid was closed and the timer started. The rat was 
returned to his home cage after all pellets were eaten. The test cage was wiped with 70% ethanol 
before and after each rat was tested for motivation. 
 
3.2.4 Experimental Diets 
After 15 days of training and baseline testing, rats were randomly assigned to 1 of 3 
diet groups. The diets were modified from the AIN-93M diet (Reeves, Nielsen et al. 1993). The 
control diet (12.5% protein) meets the nutritional requirements for this age of rat, and contained 
a protein: carbohydrate: lipid ratio of 12.5: 72.1: 4 on a weight basis (Table 3.1). The ratios for 
the 1% and 0.5% protein diets were 1: 83.5: 4 and 0.5: 84.1: 4, respectively. Animals had ad 
libitum access to food and water (except for the Montoya staircase testing days - see below), and 
were fed the specific diets for 31 days. Food intake on a cage basis was measured daily and 
individual body weight twice a week. 
 
3.2.5 Testing in the Montoya Staircase and Motivation Test 
On days 3, 15 and 30 post-diet assignment, rats were tested 2 times/day for 15 
minutes each in the Montoya staircase, with an interval of at least 2 hours in between trials. The 
methods were identical to those described above for the training period except that rats were not 
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chronically food-restricted. The total number of pellets eaten, dropped and remaining on the 
steps was counted. The mean of the two tests was used for analysis. Rats were fasted for 10 
hours before the first test of the day, to ensure sufficient motivation to perform the task. 
To ensure that experimental diet did not alter motivation to reach for sugar pellets 
in the Montoya staircase, thus confounding the test results, the motivation test was performed 
on days 2, 14 and 29 post-diet assignment, as described above. 
 
Table 3.1 Composition of experimental diets* 
Components Adequate Protein 
(Control) (g/kg) 
1% Protein Diet 
(g/kg) 
0.5% Protein Diet 
(g/kg) 
Vitamin Free Casein 140.00 11.32 5.67 
L-Cystine 1.80 0.15 0.07 
Sucrose 100.00 100.00 100.00 
Cornstarch 465.688 551.158 556.842 
Dextrinized 
Cornstarch 
155.00 184.00 184.00 
Soybean Oil (without 
tBHQ) 
40.00 40.00 40.00 
Cellulose 50.00 50.00 50.00 
Mineral Mix£ 35.000 0 0 
Mineral Mix¶ 0 35.000 35.000 
Calcium Phosphate, 
dibasic 
0 12.821 12.989 
Calcium Carbonate 0 3.070 2.931 
Vitamin Mixκ 10.000 10.000 10.000 
Choline Bitartrate 2.500 2.500 2.500 
*Diets were purchased from Dyets Inc. (Bethlehem, PA). #L-Cystine added proportionally to amount of casein. 
Amounts vary to maintain a constant ratio of total protein to total sulphur amino acid content. £AIN-93M 
mineral mix (Reeves, Nielsen et al. 1993). ¶ AIN-93M modified mineral mix with calcium and phosphorus deleted, 
potassium citrate • H2O increased from 28 to 226.55 g/kg, sucrose increased from 209.806 to 618.256 g/kg 
mineral mix. κAIN-93M vitamin mix (Reeves, Nielsen et al. 1993). 
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3.2.6 Characterization of the Malnutrition 
3.2.6.1 Tissue Collection 
On day 31, rats were deeply anesthetized (5% isofluorane) and humanely euthanized 
for tissue collection. Blood samples were collected via cardiac puncture before perfusion for later 
measurement of serum albumin, alpha-1-acid glycoprotein, and alpha-2 macroglobulin 
concentrations. Following transcardial perfusion with saline, liver was dissected on ice, 
immediately transferred to liquid nitrogen, and stored at -80°C. Blood samples were allowed to 
clot at room temperature for 30 minutes after collection, followed by centrifugation at 1,500 x g 
for 10 minutes (Eppendorf Centrifuge 5424). Serum samples were stored at -80°C. 
 
3.2.6.2 Serum Albumin Concentration 
Serum albumin concentration was determined by the bromocresol green method 
(Dumas, Watson et al. 1997). A volume of 25 µL of sample serum, blank, or standard was 
added to 5.0 mL bromocresol green solution (0.15mM bromocresol green, 0.075 M succinate 
buffer [pH 4.2], 30% Brij-35) in triplicate. After 30 minutes, absorbance was measured 
spectrophotometrically at 628 nm (Biochrom Ultrospec 3100Pro). A standard curve (2-6 g/dL) 
was made in which the concentration of serum albumin was positively correlated to measured 
absorbance. The albumin concentration of the sample was determined by linear regression, 
after calculating the mean of the triplicate samples. 
 
3.2.6.3 Liver Lipid Content 
Liver (~ 0.5 g) was homogenized in 1 mL of 0.15 M NaCl and added to 5 mL of 
chloroform:methanol (2:1). Samples were centrifuged at 3,200 x g (IEC Centra-HN) for 10 
minutes and the liver lipid pellet was isolated. To dehydrate the pellet, 1 g of anhydrous Na2SO4 
was added. The contents were filtered and washed with chloroform. The remaining chloroform 
was evaporated using a Concentrator 5301 (Eppendorf) with a Vac V-500 (Buchi) attached to a 
Vacuum Controller V-850 (Buchi). The tubes and liver samples were weighed to determine the 
lipid content of each sample. Analysis was run in duplicate. 
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3.2.6.4 Alpha-1-Acid Glycoprotein (AGP) and Alpha-2 Macroglobulin (A2M) 
Concentrations 
Serum concentrations of AGP and A2M were determined using double sandwich 
ELISA kits (Immunology Consultants Laboratory, Inc., OR, USA). Serum samples (100 µL) 
were diluted either 1:1000 for determining AGP concentration or 1:500 for measuring A2M 
concentration. Diluted serum was pipetted in triplicate into wells that had been coated with anti- 
AGP and anti-A2M antibodies, respectively. The microtiter plates were covered and incubated 
for 60 minutes. The contents of the wells were manually washed 4 times to remove unbound 
proteins. Anti-AGP or anti-A2M antibodies conjugated with horseradish peroxidase were added 
and the antibodies complexed with the previously bound markers (AGP or A2M). A 
chromogenic substrate, containing 3,3΄,5,5΄- tetramethylbenzidine and hydrogen peroxide, was 
added after 4 washes and incubated for 10 minutes in the dark. Sulfuric acid (0.3M) was added 
to stop the reaction. Since the quantity of bound enzyme varies directly with the concentrations 
of AGP and A2M in the sample, the absorbance at 450 nm is a measure of these markers in the 
samples. The concentrations of AGP and A2M were interpolated from the standard curve (five- 
parameter logistics curve) [GraphPad Prism, 5.04, California] and corrected for the dilution 
factor. All standards were run in duplicates and all samples in triplicates. 
  
3.2.7 Statistical Analysis 
Statistical analyses were performed using SPSS 18.0. Univariate Analysis of 
Variance was conducted to determine significant differences in serum albumin, AGP and A2M 
concentrations and liver lipid percentages. Tukey’s Honestly Significant Difference (HSD) was 
used whenever Post-Hoc testing was required to determine significant differences among specific 
experimental groups. Differences were considered statistically significant at p < 0.05. Mixed-
designs ANOVA was used to compare results on the Montoya staircase, motivation task, body 
weight and food intake among the diet groups over time. For body weight analysis, further 
testing with univariate ANOVA was performed on days 3 and 7.  Since the results were 
statistically significant on day 7, Tukey’s HSD was used as the post-hoc test to determine 
differences among specific groups. Differences in body weight were considered significant at the 
p < 0.017  level because of Bonferroni adjustment. For the analysis of food intake, data from 
every third day [beginning on day 3] was analyzed to allow for sufficient power to run the mixed 
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designs ANOVA. No post-hoc test was performed for food intake. 
 
3.3 Results 
3.3.1 Assessment of Protein-Energy Status 
3.3.1.1 Body Weight 
Body weight decreased significantly in both 0.5% and 1% protein groups (F(16,184) 
= 77.25, p < 0.001), showing a group-time interaction (Figure 3.1). The difference from the 
control group started being significant on day 7 (F(2,23) = 5.55, p = 0.01), but the 0.5% and 1% 
protein groups were not statistically different from one another (Tukey’s HSD; p = 0.97). Over 31 
days on experimental diet, the control group gained an average of 20.3% of initial body weight, 
while the 0.5% protein group lost 10.7% and the 1% protein group lost 5.9%. On day 31, the body 
weight of the 1% protein group was 23.2% lower than that of the control group. For the 0.5% 
protein group, body weight was 25.4% lower than that of the control group. 
 
Figure 3.1: Mean (±SEM) body weight (g) measurements showed a group x time interaction (F(16,184) 
= 77.25, p < 0.001). *The difference between the low protein groups and the control group first 
became significant on day 7, as determined by one-way ANOVA analysis (F(2,23) = 5.55, p = 
0.01). The dietary protein deficient groups were not significantly different from each other (Tukey’s HSD; 
p = 0.97). 
 
3.3.1.2 Food Intake 
Mean ± standard error of the mean (± SEM) food intake measured daily on a cage 
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basis (n = 4-5 [2 rats/cage]) is shown in Figure 3.2. Since food intake was elevated on the first 
2 days after the food restriction period in the control group, mixed-designs ANOVA was 
started on day 3. No interaction was demonstrated, but significant main-effects were observed 
for time (F(8,80) = 4.87, p < 0.001) and experimental diet group (F(2,10)= 9.58, p = 0.005). A 
decrease in food intake occurred in the 0.5 and 1% protein groups. Compared to control intake, 
the decrease was of 20.6% and 15.9%, for 0.5 and 1% protein groups, respectively. No further 
testing was performed due to insufficient statistical power. 
 
 
 
Figure 3.2: Food intake (mean ± SEM) of rats fed low protein diets was lower than that of control fed rats. Food 
intake was decreased 20.6% by feeding a 0.5% protein diet and 15.9% by feeding a 1% protein diet. Food intake 
was measured daily,  based on cage data (n = 4-5 [2 rats/ cage]). Food intake changed as time progressed 
(F(8,80) = 4.27, p < 0.001). There was a significant difference in food intake among diet groups (F(2,10) = 
9.58, p = 0.005). Dashed line on day 3 indicates when analysis was started. 
 
3.3.1.3 Liver Lipid Content 
Figure 3.3 demonstrates that liver lipid content was altered by experimental diet 
(F(2,23) = 61.83, p < 0.001). Both the 0.5% protein and 1% protein diet groups increased liver 
lipid relative to the control group (Tukey’s HSD, p < 0.001). There was no significant difference 
between the 0.5% and 1% protein groups (p = 0.13). 
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Figure 3.3: Liver lipid content was increased by both low protein diets. Data are presented as mean (±SEM). 
Liver lipid weight was calculated as a percentage of liver wet weight (0.5% protein = 44.9 ± 1.8%; 1% 
protein = 37.3 ± 4%; Control = 7.7 ± 1.2%). One-way ANOVA showed a significant difference among 
groups (F(2,23) = 61.83, p < 0.001). Experimental groups not sharing a common superscript letter were 
significantly different by Tukey’s HSD (p < 0.001). 
 
3.3.1.4 Serum Albumin 
Mean (± SEM) serum albumin concentration shown in Figure 3.4 was significantly 
influenced by diet (F(2,23) = 4.81, p = 0.018). Only the 0.5% protein diet decreased serum 
albumin concentration significantly relative to the control group (Tukey’s HSD, p = 0.015). The 
0.5% and 1% protein groups did not differ from one another (p = 0.53), nor did the 1% protein 
and control groups (p = 0.16). Serum albumin concentration was, on average, reduced by 22.2% 
in the 0.5% protein group when compared to control values. 
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Figure 3.4: Serum albumin concentration (mean ± SEM) was decreased by the 0.5% protein diet (0.5% = 4.4 
± 0.2 g/dL; 1% = 5.1 ± 0.3 g/dL; Control = 5.6 ± 0.2 g/dL). One way ANOVA showed a significant 
difference among groups (F(2,23) = 4.81, p = 0.018). Experimental groups not sharing a common 
superscript letter w e re significantly different by Tukey’s HSD. The mean reduction in serum albumin 
concentration was 22.2% in the 0.5% protein group. 
 
3.3.1.5 Serum Alpha-1-Acid Glycoprotein 
Figure 3.5 shows that serum AGP concentration was increased by feeding low 
protein diets (F(2,23) = 35.84, p < 0.001). Tukey’s HSD post-hoc test showed significant 
differences between the 0.5% and 1% protein groups (p < 0.001), as well as between the 0.5% 
protein and control group (p < 0.001), and between 1% protein and the control group (p = 0.031). 
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Figure 3.5: Low protein diets elevated mean (± SEM) serum alpha-1-acid glycoprotein concentration 
(one-way ANOVA, F(2,23) = 35.84, p < 0.001), and 0.5% protein had the largest effect (0.5% = 
195.5 ± 25 mg/L; 1% = 83.9 ± 6 mg/L; Control = 30.2 ± 5 mg/L). Experimental groups not sharing 
a common superscript letter were significantly different by Tukey’s HSD (p < 0.001 level). 
 
3.3.1.6 Serum Alpha-2 Macroglobulin 
The influence of experimental diet on serum A2M concentration is shown in Figure 
3.6. Dietary protein had a statistically significant effect (F(2,23) = 74.04, p < 0.001). Both low 
dietary protein groups had significantly increased serum A2M concentration when compared to 
the control group (p < 0.001), and the 0.5% protein diet caused a greater increase than the 1% 
protein diet (p < 0.001). 
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Figure 3.6: A diet containing 0.5% protein elevated mean (± SEM) serum A2M concentration to a 
greater extent than a 1% protein diet (0.5% = 166.2 ± 6.7 mg/L; 1% = 105.7 ± 4.6 mg/L; Control = 55.7 
± 7.3 mg/L). One way ANOVA showed a significant difference among groups (F(2,23) = 74.04, p < 
0.001). Experimental groups not sharing a common superscript letter were significantly different by 
Tukey’s HSD (p < 0.001). 
 
3.3.2 Motor Skills Assessment 
3.3.2.1 Montoya Staircase Test 
The influence of experimental diet on performance in the Montoya staircase test, 
expressed as a percent of baseline performance, is shown in Figure 3.7. Three rats did not meet 
criteria set for the Montoya staircase by the end of the training period and thus were not included 
in the testing. Mixed-designs ANOVA demonstrated no significant differences among groups 
over time (F(4,40) = 1.37, p = 0.26). Group and diet main-effects were not statistically 
significant (p > 0.05). 
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Figure 3.7: Low protein diets did not alter performance in the Montoya staircase after 3, 15, or 30 days 
of exposure to experimental diet. Data are expressed as mean (± SEM) performance as a % of baseline 
performance before assignment to experimental diet. No group x time interaction was observed (F(4,40) = 
1.37, p = 0.26). The effect of time was not significant (p = 0.59), nor was the effect of dietary protein (p = 
0.72). 
 
3.3.2.2 Motivation to Reach for Sugar Pellets in the Montoya Staircase 
The results in Figure 3.8 show the results of the motivation task expressed as the 
absolute time to eat 10 sugar pellets. All groups took less time to eat the 10 sugar pellets on 
repeated testing (Mixed-designs ANOVA, F(2,46) = 11.52, p = 0.0004). There was no main-
effect of experimental diet (p = 0.19) or interaction of diet and time (p = 0.22).  
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Figure 3.8: All experimental groups ate the sugar pellets more quickly with increased exposure to them 
(time), but this was not significantly altered by experimental diet. The results of the motivation task are 
shown as the mean (± SEM) time in minutes to eat 10 sugar pellets. Rats performed differently at each time 
point (Mixed-designs ANOVA, F(2,46) = 11.52, p = 0.0004), but showed no main-effect of 
experimental diet (p = 0.19) or interaction of diet and time (p = 0.22).  
 
3.4 Discussion 
The primary goal of this study was to develop an experimental model of PEM that 
would serve as a clinically relevant mimick of the malnutrition that arises after stroke. The 
features of the post-stroke protein-energy malnourished patient important to imitate in the rat 
included the diminished food intake and the mild to moderate acute drop in body weight (less 
than 10% in a month (Jönsson, Lindgren et al. 2008, Finestone, Greene-Finestone et al. 2003)), 
which also affects the biochemical markers of malnutrition. All the mentioned characteristics 
should be diagnosed with the best methods available for rats, which frequently are not the same 
as those used in humans. Besides weight loss, the focus for nutritional diagnosis in human 
studies is usually serum albumin. Rarely do the studies consider the potential effects of 
inflammation on the expression of this marker, and thus the acute-phase proteins measured in our 
study are not found in human studies of PEM following stroke. They are, however, recognized as 
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good markers of the acute-phase response in humans (Kaysen, Dubin et al. 2000), as well as in 
rats (Lyoumi, Tamion et al. 1998). The analysis of liver lipid content, common in rodent studies 
(Bobyn, Corbett et al. 2005, Lamri, Meghelli-Bouchenak et al. 1995, Kwon, Kang et al. 2012), is 
also not commonly estimated in human studies even though PEM in humans also causes fat 
infiltration into the liver (Garrow, Fletcher et al. 1965, Waterlow 1975, Fong, Nehra et al. 2000). 
Our results showed that both low protein diets caused weight loss, and the range of 
all individual rats in both groups was 1.7- 4.9% after seven days, which is characteristic of the 
desired acute PEM state (Jönsson, Lindgren et al. 2008). After 2 weeks being fed protein 
deficient diets, rats had lost 2.5-7% of their initial body weight. The literature regarding 
nutritional status of stroke patients shows a similar pattern of weight loss. Gariballa et al. (1998) 
showed a 2.8% decrease in body weight 2 weeks after stroke. Unosson et al. (1994) reported a 
drop in weight of 2.3% at 2 weeks after stroke. After 4 weeks on 0.5% protein diet, our rats 
showed a 10.7% decrease in body weight from the beginning of the study, whereas the 1% 
protein diet caused a 5.8% weight loss. Finestone et al. (1995) reported that after 4 weeks, 14% 
of stroke patients had lost 5-15% of their usual weight (collected as weight before stroke, 
reported by patient or family member). The authors classify this weight loss as a sign of mild 
malnutrition, which is the severity we aimed to achieve with our study. Although similar, it is 
important to acknowledge the limitations of the comparisons. The Finestone et al. (1995) study 
reported weight, which, especially when dealing with elderly patients, could show biased results. 
Also, the adult rats used in our study are past their rapid growth slope (Duffy, Lewis et al. 2002), 
which has advantages over studying adolescent rats. However, the comparison with the human 
situation still has limitations, since the rat continues to grow until 96 weeks, although at a much 
slower rate (Levin, Keesey 1998, Duffy, Lewis et al. 2002). 
Over the 31 days on diets, protein deprived rats showed diminished food intake. The 
1% protein group consumed 15.9% less food than the control animals, whereas the 0.5% protein 
group had a more dramatic decrease in food consumption of 20.6%. This diminished food intake 
caused the energy deficit, which combined with the protein deficiency of the diets caused the 
desired PEM. One study after stroke showed a similar decrease in food intake of 15.9% in an 
orally fed group over 21 days (Foley, Finestone et al. 2006). However, an unusual pattern was 
observed in food intake in the current study. First, food intake on the first 2 days after  
assignment was peculiarly high, which is likely due to the previous food restriction required for 
48  
training in the Montoya staircase. The hypothesis is that after being restricted for 15 days, 
animals were trying to compensate and eat more, after which food intake appeared to stabilize on 
the third day. The protein deprived groups, because of the introduction to the new diets, ate less 
than the control group. Thus, these first few days of data are less reliable data for documenting 
how the low protein diet affects food intake and how soon the low protein diets cause the 
voluntary reduction in food intake. These results highlight a limitation to our experimental 
design, as a period of free access to control diet (i.e., wash-out period) should have been provided 
before assigning the animals to their experimental diet groups. Had this been done, it is quite 
possible that the food intake of the three experimental groups would appear similar on days 1-3. 
Another limitation of the study is that the acute nature of the PEM models could be assessed only 
on the basis of daily food intake and body weight measured 2 times per week. All other 
diagnostic tools were only assessed after 31 days. It is suggested that future studies assess serum 
acute-phase proteins and liver lipid content at earlier time points to allow for a more complete 
diagnosis of the type of PEM and how it evolves. 
The biochemical data support the conclusion that both deficient diets induce PEM. 
However, the diet containing 0.5% protein is the one that is best suited to produce mild to 
moderate acute PEM in adult rats. Both protein deficient diets caused liver lipid content to be 
increased, but the severity of the protein depletion did not affect liver lipid accumulation. Our 
animal study provided animals with a balanced diet prior to assignment into deficient diets. In  
the clinical reality, conversely, many people are consuming the typical Western diet, high in 
saturated fats and sugars, prior to having a stroke. Future studies could be designed to feed 
Western diets prior to stroke and the development of PEM. As a Western diet also triggers the 
development of fatty liver (Zivkovic, German et al. 2007), the effects of post-stroke PEM may be 
further magnified by the previous dietary history. 
Another objective of this study was to assess the degree of acute-phase response 
induced by the models of PEM. A decrease in serum albumin occurs with low dietary amino acid 
availability (Qu, Ling et al. 1996) such as would occur with the 0.5% and 1% protein diets. 
However, the increase in the serum concentration of the positive acute-phase proteins, AGP and 
A2M, suggest that at least some of the decline in serum albumin is due to inflammation. These 
results extend previous findings reported in adolescent rats fed low protein diets (Lyoumi et al. 
1998, Smith, Andrade Ramos et al. 2013) to less severe PEM in more slowly growing adult rats. 
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In our study, rats fed 0.5% protein diet showed a greater acute phase response on the basis of 
higher concentrations of both positive acute phase markers; this was not the case with the 
negative acute phase reactant, albumin. The acute-phase response in malnourished stroke 
patients would be important to characterize in future studies, as it has not yet been described. 
Overall, the analyses of inflammatory markers in this study strengthen the previous idea that 
PEM can independently cause an acute-phase response (Ling, Smith et al. 2004), since there was 
no other stimulus present. 
Since our dietary prototype did not influence performance on the Montoya staircase 
test, this behavioural protocol can be reliably used in future studies with the goal of studying 
whether nutritional status influences post-stroke deficits. The effects of PEM on motor skills 
have previously only been studied during the developmental period. One rat study previously 
showed that maternal malnutrition resulted in a delay in reflex maturation and locomotor activity 
evolution in pups in the postnatal period (Barros, Manhães-De-Castro et al. 2006). However, 
these investigators did not use purified diets, the low-protein diet was manipulated with use of 
food ingredients, and unmatched rat chow was fed to control rats. This approach cannot 
guarantee isocaloric diets between PEM and control groups or diets matched for micronutrients, 
and thus the effects cannot be attributed to PEM with certainty. A more recent study on mice 
confirmed that animals born to protein-energy malnourished mothers have delayed motor 
development, and in this case the nutrition protocol was well designed, with purified, well- 
matched diets (Ranade, Sarfaraz Nawaz et al. 2012). One human study correlated PEM in early 
infancy with poorer motor abilities in adolescence (Hoorweg, Stanfield 1976). Another study 
established that motor scores were significantly lower in malnourished children than in normal 
counterparts, especially in chronically malnourished children (Reyes, Valdecanas et al. 1990). 
Although these studies relate malnutrition with poor motor function, this has not previously been 
studied in the adult. To my knowledge, this is the first study to assess the relationship between 
PEM in adult rats and skilled motor abilities. One study limitation that must be noted, however, 
is that motor performance was assessed by two measurements performed on the test day. This 
did not follow the recommendation to test on a minimum of two independent days for preclinical 
stroke models, which is intended to capture intra-animal variability in performance (reviewed in 
Kleim, Boychuk et al. 2007). This may have reduced the sensitivity for detecting small 
differences between the experimental groups. However, in stroke studies, a careful design should 
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also consider that multiple testing can also act as rehabilitation in addition to outcome 
assessment. 
This study also demonstrated that evolving PEM did not alter the rats’ motivation to 
obtain the sugar pellets, making it a valid test for studying the effects of PEM in the post-stroke 
period. Altered motivation would have compromised the use of the Montoya staircase to test 
motor skill as intended. Interestingly, the malnourished animals followed the same pattern as 
control animals, and increased the speed at which they ate the sugar pellets each time they were 
tested. This is likely explained by the need, on the first testing day to take longer to acclimatize 
to the cage; with increasing exposure over time, the rats did not need to perform cage 
recognition before going after the pellets. Thus, the acclimatization factor reduces time to find 
pellets in subsequent trials. However, some observations suggest that this task could be refined 
to be a better test of motivation. For example, random placement of pellets in the cage has an 
effect on how fast rats are able to eat the sugar treats. For instance, if most pellets fall into a 
corner and the animal does not need to explore the cage to find pellets, this is another 
explanation, in addition to motivation, for an increase in speed. For further studies, consistently 
placing both the pellets and the rat in pre-selected spots in close proximity would possibly 
render more accurate results. Also, an automated activity chamber could be used for tracking 
locomotor activity to determine whether there are any differences among experimental groups. 
A period of exposure to an empty cage prior to the addition of sugar pellets would also allow 
familiarity with that environment prior to testing so that this aspect would not confound the test 
of motivation to eat the sugar pellets. Finally, although the low-protein diets did not 
significantly affect rat motivation to eat sugar pellets, it is noteworthy that a trend towards 
malnourished animals being more motivated appeared to be developing. Thus, it is 
recommended that future studies of malnourished rats always include a test of motivation, with 
the suggested adaptations, particularly if the test period exceeds 30 days. 
In summary, this study showed that feeding a 0.5% protein diet for 31 days produces 
an acute, moderate PEM with some similar features to what is observed in human patients after 
stroke. This model is suitable for use in future experimental stroke studies because it does not 
affect motor ability in the Montoya staircase test and does not change motivation to reach for 
sugar pellets. 
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CHAPTER 4 
ESTABLISHING THE PHOTOTHROMBOTIC FOCAL ISCHEMIA MODEL 
 
4.1 Introduction 
The PEM that develops after stroke may worsen recovery (Martineau, Bauer et al. 
2005, Yoo, Kim et al. 2008). Experimental models of global brain ischemia have shown that 
PEM can have effects on both the brain cell death cascade (Bobyn, Corbett et al. 2005) and 
plasticity mechanisms that aid brain repair (Prosser-Loose, Verge et al. 2010). However, these 
studies have addressed the effects of PEM present at the time of brain ischemia, which is a 
problem affecting around 16% of patients (Gariballa, Parker et al. 1998a, Gariballa, Parker et al. 
1998b). While important, PEM developing after brain ischemia affects a much larger segment 
(35-49%) of patients (Shen, Chen et al. 2011, Chai, Chu et al. 2008, Poels, Brinkman-Zijlker et 
al. 2006). Also, the effects have never been studied in a focal ischemia model, which is a better 
mimick of stroke. To address both the functional and biochemical effects of post-stroke PEM, a 
reliable experimental stroke model is needed to combine with the PEM model developed and 
described in Chapter 3. 
The photothrombotic stroke model is a good model choice, because it mimicks active 
clot formation in human stroke (Watson, Dietrich et al. 1985). Also, it does not require as 
invasive surgery, such as a craniotomy, as some other accepted models. When studying 
malnutrition effects, it is particularly important that the stroke model not require extensive 
surgery, since the latter has dramatic effects on nutritional status and could confound the study of 
stroke. The metabolic response to surgery increases mobilization of glucose and fat, increases 
lipolysis and gluconeogenesis, decreases utilization of insulin, and generates hyperglycemia 
(Cuthbertson, Fell et al. 1972). Major surgery thus increases protein and energy requirements 
dramatically (Hill, Douglas et al. 1993), and this is not a feature observed in stroke patients 
(Finestone, Greene-Finestone et al. 2003). Thus, choosing a model that minimizes these effects is 
important. Another advantage of the photothrombotic stroke model is that it can be readily 
applied to both adult and aged rats, which best mimicks the majority of stroke cases (Brown, 
Marlowe et al. 2003, Badan, Buchhold et al. 2003). Nevertheless, there are also recognized 
limitations of this model, the main one being vasogenic edema, which is atypical of human 
stroke (Carmichael 2005). This can be overcome with long term endpoints that allow for 
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resolution of edema. Another limitation for neuroprotection studies (such as drug candidate 
studies) is the lack of reperfusion and consequently a penumbra (Carmichael 2005). However, 
this does not present limitations for the intended post-stroke PEM studies that are hypothesized 
to exert effects through plasticity mechanisms. Modifications to the method have also been 
proposed to overcome this limitation to produce a penumbra-like region (Hilger, Blunk et al. 
2004). 
The photothrombotic stroke model was created by Watson and colleagues (1985). A 
thrombus was produced via a photochemical method to occlude the cerebral microvasculature 
(Watson, Dietrich et al. 1985). They injected a photosensitive dye and irradiated the exposed 
skull with a green light from a filtered arc lamp. Platelet aggregates were observed in the vascular 
endothelium, resulting in occlusion. However, Rosenblum and el-Sabban (1977) were the ones 
who originally pioneered the idea of photo-altering dye for thrombus formation. They used 
sodium fluorescein dye and blue light in mice to occlude pial vessels. Since the dye was capable 
of absorbing light, it was thought to produce damage to the endothelium because of heat 
transmission and to cause platelet aggregation (Rosenblum, el-Sabban 1977). However, the dye 
reemitted the absorbed light by fluorescence and was not very efficient. The use of other dyes 
was shown to be more efficient, rose Bengal being one of them (reviewed in Watson 1998). 
Disodium tetrachlorotetraiodofluorescein, known as rose Bengal, is very efficient in injuring the 
endothelium. The energy absorbed by the dye when irradiated is transferred to the heavy atom of 
iodine in the structure. Because of this light-iodine interaction, oxygen becomes excited (singlet 
state), and singlet oxygen directly interacts with endothelial lipids and proteins, and causes 
peroxidation. The result is a damaged endothelium that attracts and causes platelets to aggregate 
(Watson 1998). However, the triplet state of the photosensitized dye acts as a free radical and can 
lead to other damaging reactions (Dietrich, Busto et al. 1987). The photothrombotic phenomenon 
is cumulative and generated by the rate of endothelial damage and the response of the platelets to 
this damage (Dietrich, Busto et al. 1987). 
Consistency in any experimental stroke model is essential to allow for the study of 
cause and effect (Carmichael 2005). Thus, in establishing this model in our laboratory, reliability 
needed to be assessed. Since infarct location and extent influence post-stroke function and brain 
reorganization, histological methods are used to assess infarct volume, ensure consistent infarct 
location, and interpret the accompanying functional measurements (Carmichael 2005). The final 
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volume of infarct is determined by the: [1] type and concentration of the dye; [2] type and 
intensity of irradiation source used; [3] irradiation time; and [4] resolution of edema (Watson, 
Prado 2009). In the present study, it was hypothesized that laser irradiation at 532 nm (25 mW 
power in a 5 mm diameter) targeted to the forepaw area of the cortex for 10 minutes combined 
with 30 mg/kg body weight of rose Bengal injection would result in medium size infarcts 
associated with motor alterations of the targeted forelimb. The parameters used in this 
methodology are known to occlude 10 to 40 µm diameter cortical vessels (Watson, Prado 2009). 
A major objective was to determine the consistency of the model by measurements of infarct 
volume. 
The motor cortex is a common site of human stroke, which often results in limb 
impairments or paralysis (Fridman, Hanakawa et al. 2004, Chollet, Dipiero et al. 1991, Liepert, 
Storch et al. 2000). In the photothrombotic model, a reproducible infarct in the motor cortex 
associated with a functional domain (such as forepaw use) can be produced (Watson, Dietrich et 
al. 1985) and generate alterations in sensorimotor function (Moon, Alaverdashvili et al. 2009, 
Alaverdashvili, Moon et al. 2008, Maxwell, Dyck 2005, Brown, Aminoltejari et al. 2009, 
Markgraf, Green et al. 1994, Markgraf, Kraydieh et al. 1993). Forepaw impairments resemble 
human limb disabilities, and thus are useful for the study of motor recovery. Photothrombotic 
stroke in the forelimb area of the motor cortex should result in defined functional deficits, which 
are essential to characterize in experimental stroke models to allow for understanding of 
behavioral alterations and neuroplasticity. The Montoya staircase and cylinder test are well- 
validated for experimental stroke assessment (Jackson 2009). The Montoya staircase is a food 
rewarded test that can quantitatively assess the ability of a trained rat to reach. After focal 
ischemia, animals are expected to have an impaired capacity to retrieve sugar pellets and to show 
some recovery as the post-stroke period progresses (Montoya, Campbell-Hope et al. 1991). Rats 
also show alterations in their ability to support themselves with the affected paw after stroke. The 
cylinder test, which is a non-baited assessment, allows for the observation of paw preference and 
postural support of the rat placed inside a cylinder (Gharbawie, Whishaw et al. 2004). Functional 
post-stroke assessment is a critical supplement to histological findings, because often infarct size 
does not predict the degree of disability. Also, whereas histology is limited to one terminal time 
point, behavior can be measured at multiple times to show the rate of recovery (Lemon, Griffiths 
2005, Hossmann 2006). Thus, the second objective in this study was to evaluate the consistency 
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of the motor alterations after stroke by behavioural assessments. 
Another important aim of a newly developed laboratory stroke model is incomplete 
functional recovery, since that is what most often occurs in the clinical reality. Stroke has a high 
disability rate among survivors (Go, Mozaffarian et al. 2013). Since 76% of stroke patients 
survive, the support to disabled individuals represents more than 56% of the annual cost of stroke 
(Statistics Canada 2011). Stroke has a major impact on quality of life. For example, one study 
showed that only 36.8% of stroke survivors report themselves as being in good health (Centre for 
Chronic Disease Prevention and Control, Health Canada Canadian Cardiovascular Society Heart 
and Stroke Foundation of Canada 2003). In 2000, a high percentage of individuals (77.2%) who 
had a stroke reported having activity restrictions and needing help with activities of daily living 
(Centre for Chronic Disease Prevention and Control, Health Canada Canadian Cardiovascular 
Society Heart and Stroke Foundation of Canada 2003). The degrees of impairment and disability 
depend on the type and severity of stroke, but also on the location of the infarct (de Haan, 
Limburg et al. 1995). Thus, while stroke patients can exhibit some functional recovery after the 
initial degree of disability, recovery is incomplete for most patients. Rat stroke models also 
demonstrate spontaneous recovery (reviewed in Murphy, Corbett 2009), but the extent varies 
among different models and with varying methodological refinements. In order to mimick the 
clinical reality, the third study objective was to investigate whether the model developed would 
meet the aim of incomplete functional recovery after 30 days. 
 
4.2 Materials and Methods 
4.2.1 Experimental Design 
Adult, male, Sprague-Dawley rats, 13 weeks old (N=18) were caged in groups of 2 
or 3. Rats were acclimatized to the facility for 3 days with ad libitum access to control diet (see 
below). On the fourth day, animals were removed from the colony to the behavioral room where 
they remained for 30 minutes in their cages, before being handled for 10 minutes each. Daily 
handling continued for 1 week. During this time, animals were weighed daily to allow them to 
acclimate to the procedure. Food intake was measured, during the first week to permit 
calculation of the food restriction to be imposed during the training period. Over the next 15 
days, rats were exposed to behavioural training in the Montoya staircase task 2 times/day. They 
were then randomized to either sham surgery (SHAM) or focal ischemia (ISCHEMIA). The 
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sample size was 15 rats in the ISCHEMIA group and 3 animals in SHAM group. The rationale 
for the small sample size in the SHAM group was that their main purpose was to provide normal 
brain specimens for histological comparison. 
To assess pre-stroke baseline (day before surgery) and post-stroke sensorimotor 
function, two validated functional tests were used, the cylinder test (on days 3 and 30 post- 
surgery) and the Montoya staircase test (on days 3, 15 and 30 post-surgery). Rats were 
humanely euthanized on day 31, with the exception of 2 animals euthanized on day 30 due to 
ethical reasons related to tail necrosis. Brains were then collected for histological assessment of 
infarct volume. The details of each step in the experimental design are provided below. This 
work was approved by the University of Saskatchewan’s Animal Research Ethics Board and 
adhered to the Canadian Council on Animal Care guidelines for humane animal use. 
 
4.2.2 Diet 
The control diet used in this experiment was identical to that used in the first study 
and described in Chapter 3 (Table 3.1). Body weights were obtained on a weekly basis, except 
during the Montoya staircase training period and for 4 days following the surgery, when body 
weight was measured daily. 
 
4.2.3 Montoya Staircase Training and Pre-Stroke Performance Assessment 
Rats were trained in the Montoya staircase task as described in Chapter 3. All rats 
were food restricted by 15% during the first week of training and 10% during the second week of 
training to provide sufficient motivation to reach for the banana flavored sucrose pellets 
(TestDiet, Richmond, IN). During the training period, rats were left in the chamber for 15 
minutes and the total number of pellets eaten, dropped and remaining on the steps was recorded. 
This procedure was repeated after 2 hours, to allow for 2 training sessions per day. 
Baseline (pre-stroke) performance testing in the Montoya staircase was done on the 
night before surgery at the end of the training period, under the same conditions used for training 
days. Animals were tested twice for 15 minutes each, with a 2 hour interval. Rats that were able 
to eat ≥ 12/21 pellets and a standard deviation of ≤ 2 over a period of 8 trials were included in 
the post-stroke Montoya staircase testing. Those rats that did not meet this criteria (n = 2) were 
still assigned to surgical groups and used for all other assessments. 
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4.2.4 Cylinder Task: Pre-Stroke Performance Assessment 
This test assesses spontaneous forelimb use (asymmetry) during exploration. The 
pre-stroke baseline test took place on the day prior to surgery. This test also served to determine 
preferred paw, so that the infarct could be placed in the hemisphere contralateral to this paw and 
thus affect function of this paw. Animals were placed into a Plexiglass cylinder (20 cm diameter) 
situated on a glass tabletop and were videotaped from below. Rats were left in the cylinder for 5 
minutes and a minimum of 20 independent wall contacts. Since 3 animals did not have the 
minimum required number of touches in 5 minutes, each remained in the cylinder for an 
additional 7 minutes. The videotapes were later viewed by a blinded observer to count the 
number of forelimb wall contacts (single and bilateral) used for postural support. Forelimb use 
preference was calculated as follows: 
• For ISCHEMIA rats, percent affected limb use was calculated using the following 
formula: [(contralateral forelimb contacts + 1/2 bilateral contacts) / (total contacts)] x 100% 
(Woodle, Asseo-Garcia et al. 2005). 
• For SHAM rats, percent preferred limb use was calculated as: [(preferred 
forelimb contacts + 1/2 bilateral contacts) / (total contacts)] x 100% (Woodle, Asseo-Garcia et al. 
2005). 
 
4.2.5 Surgical Induction of Stroke 
For photothrombotic stroke, the method was modified from that described by Watson 
and colleagues (Watson, Dietrich et al. 1985) and performed under sterile conditions. Rats, now 
16 weeks old, were anaesthetised with 4% isoflurane in an induction chamber. Animals were 
transferred to the surgical area after their heads were shaved. Once placed in the stereotactic 
device, the incision site on the skull was cleaned 3 times with chlorhexidine soap followed by 
70% ethanol and a 1-2 cm midline incision was made through the scalp from between the eyes to 
between the ears. The skin was held open with bulldog clamps to keep the skull exposed.  The 
hemisphere contralateral to the preferred side was used for placement of a unilateral lesion. 
 
The region of interest was defined using the following stereotaxic coordinates: +2 
mm to -1 mm anterior-posterior from Bregma and from +2 mm to +5 mm lateral of midline, 
chosen to target the area of forepaw sensorimotor cortex (Paxinos, Watson 1998). Using a 
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stereotaxic frame, this region was demarcated and the overlying skull was thinned with a bone 
drill until brain surface blood vessels were visualized, when the skull was dry, under a dissecting 
microscope at x16 magnification. The area surrounding the thinned box was colored with a black 
sharpie marker to avoid laser refraction. The rat tail was then cleaned with warm water and 
chlorhexidine soap, and a tourniquet was applied.  A catheter (BD Insyte IV catheter, 24GA 
0.75IN) was inserted into the lateral tail vein, the tourniquet and needle were removed,  and the 
syringe containing the 30 mg/kg body weight dose of rose Bengal (using a stock concentration of 
100 mg/ml) was attached to the catheter. The syringe was kept covered in tin foil to avoid light 
degradation. At this point, a 532 nm green laser (Laserglow Technology) delivering 25mW in a 
5 mm diameter was moved into position above the thinned area of the skull. The timer was 
started just as the rose Bengal infusion began and was set to maintain illumination for 10 
minutes, allowing for photoactivation of the dye. Rose Bengal dye was injected over 45 seconds 
into the tail vein, followed by sterile saline injection (over 45 seconds) to clear the catheter. The 
homoeothermic blanket system was set to maintain rectal temperature controlled to 37 ± 0.2 C°. 
Following photostimulation, the tail vein catheter was removed. The head incision was sutured 
and local anesthetic (bupivicane, 2mg/kg) in physiological saline was injected in the surrounding 
area. For fluid replacement, a subcutaneous injection of sterile physiological saline (0.9%) was 
administered into the scruff of the neck. Sham animals were treated identically (including time 
under anaesthesia) except that the laser was not turned on. Physiological variables monitored 
included: [1] Pulse, measured by the multiparameter monitor (Lifewindow 6000V), [2] oxygen 
saturation, measured by pulse oximetry in the multiparamenter monitor (Lifewindow 6000V), 
[3] respiration rate (breaths/minute), measured by counting the number of breaths in 15 seconds 
and multiplying by 4, and [4] rectal temperature, measured by rectal probe. 
During the post-surgical period, rats were monitored twice daily for the first 4 days, 
and then once a day for the remainder of the study. 
 
4.2.6 Post-Stroke Functional Assessments: Montoya Staircase and Cylinder Testing 
 
For the testing period after the focal ischemia (on days 3, 15 and 30 post-stroke), 
animals were tested in the Montoya staircase 2 times/day for 15 minutes each, with an interval of 
at least 2 hours in between trials. The total number of pellets eaten, dropped and remaining on 
the steps was counted for analysis. The mean of the two tests was used for analysis. Reaching 
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success was expressed as a percent of baseline performance and calculated as: 
• For ISCHEMIA rats: [(number of pellets retrieved and eaten with the affected 
paw on testing day)/ (number of pellets retrieved and eaten with the affected paw at pre-stroke 
baseline)] x 100%. 
• For SHAM rats: [(number of pellets retrieved and eaten with the preferred paw on 
testing day)/ (number of pellets retrieved and eaten with the preferred paw at pre-surgery 
baseline)] x 100%. 
Cylinder testing took place on days 3 and 30. Animals were video recorded in the 
cylinder for 5 minutes, with the exception of the 3 animals who did not reach criteria at baseline; 
each of these rats remained in the cylinder for a total of 12 minutes. The percent affected/ 
preferred limb use was calculated as described above in Section 4.2.4. 
 
4.2.7 Histological Assessment of Infarct Size 
 
Rats were transcardially perfused with 0.9% saline followed by 4% 
paraformaldehyde. The heads were placed in a 4% paraformaldehyde solution for 24 hours. 
Brains were then dissected, postfixed in 4% paraformaldehyde overnight and then transferred to 
another jar containing 20% sucrose in phosphate buffered saline(PBS) for 3 days. Subsequently, 
brains were placed in OCT (Optimal Cutting Temperature) compound for 30 minutes, after 
which they were frozen using dry-ice cooled isopentane in a mold containing the OCT 
compound. Samples were stored at -80°C until sectioning. Coronal brain sections (40 µm thick) 
extending throughout the infarct were cut in a cryostat. Every third section was collected for 
cresyl violet staining. 
The brain sections were inspected under a light microscope (Nikon Eclipse 50i). 
Digital images were captured using the DS-Fi1 camera attached to the microscope (Nikon 
Eclipse 50i) on 10x magnification. Each section was assigned the coordinate from Bregma in 
accordance with a rat brain atlas (Paxinos, Watson 1998). If two hemispheres in a given section 
were asymmetrical (at different coordinates due to sectioning artifact or stroke-associated 
displacement), a coordinate was defined for each hemisphere. Since a considerable number of 
sections were of poor histological quality, each brain section was classified as “usable” or 
“unusable” based on staining and sectioning quality. If the region of infarction was obscured or 
damaged, it was discarded from further analysis. The minimum number of sections used to make 
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a volume estimate was 12. 
For each section judged to be of adequate quality, the dorsal border of the infarct was 
traced using a template of contralateral (healthy) hemisphere (a mirror image). The border of the 
infarction was then traced, and this included both necrotic tissue and the surrounding reactive 
gliosis. The area of infarct (mm2) was measured using the Image/J software from National 
Institutes of Health (NIH) (http://rsb.info.nih.gov/ij/download.html). The area was measured 3 
times, and the resulting average “infarction area” for each section was used for a volume 
calculation. The distance between “usable” sections was calculated and was referred to as the 
“corrected between section interval” considering the number of “unusable”, rejected brain 
sections. The volume of brain infarct for each rat was calculated using the following equation: 
 
Infarct volume (mm3) each animal 
= 
∑ [Infarct area of each section (mm2) x Corrected between section interval (mm)] 
 
 
 
4.2.8 Statistical Analysis 
 
Statistical analysis was performed using SPSS 18. Behavioral endpoints were treated 
as interval data and tested for normality. Repeated measures ANOVA was used to analyse 
ISCHEMIA group on: reaching success on Montoya staircase over time (days 3, 15 and 30), 
affected limb use for support in the cylinder test over time (days 3 and 30), and pattern of limb 
use in the cylinder over time (days 3 and 30). The large difference in group size between the 
ISCHEMIA and SHAM groups would not allow for an unbiased comparison and thus, the 
SHAM group was not included in the analysis. Post hoc analysis, where applicable, was done 
using paired T-tests. 
To establish if motor function was related to the extent of cortical damage, the 
correlation between infarct volume and motor deficit in the Montoya staircase and cylinder test, 
at each time point (days 3, 15 and 30 for Montoya staircase and days 3 and 30 for cylinder) was 
determined by Pearson’s correlation. 
A multiple regression analysis was performed to examine the effects of tail necrosis 
on behavioural endpoints (Montoya staircase performance on days 3, 15 and 30, and cylinder 
performance on days 3 and 30) and infarct volume. 
Statistical significance for all analyses was set at p < 0.05. 
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4.3 Results 
4.3.1 Pre and Post-Surgical Outcomes 
 
Physiological variables monitored during surgery are summarized in Table 4.1. The 
mean ( + SEM) presented for the group was calculated from the mean values over the surgical 
period for each animal. Ranges show the lowest and highest values obtained for the group and 
thus demonstrate inter-animal variability. Both oxygen saturation and temperature were kept 
within a tight range. The range in oxygen saturation was 98 –100% in both groups. Mean (± 
SEM) temperature was 36.8 ± 0.1°C and 36.8 ± 0.3°C for ISCHEMIA and SHAM groups, 
respectively. Pulse rate had wider inter-animal variability, and thus the mean (± SEM) pulse rate 
was 301.4 ± 4.9 beats per minute in the ISCHEMIA group, and 308 ± 8.8 beats per minute in the 
SHAM group. Over the dye injection period, 6 animals (5 ISCHEMIA and 1 SHAM) showed a 
brief ~ 60% decrease in pulse rate, which returned to normal in  < 40 seconds. Another set of 4 
animals (2 ISCHEMIA and 2 SHAM) lost pulse for about 20 seconds and returned to normal 
after that. 
After surgery, ISCHEMIA rats lost an average (± SEM) of 0.9 ± 0.1% of their pre- 
surgery weight, whereas SHAM animals had a mean ± SEM drop of 0.8 ± 0.1% relative to their 
pre-surgery weight. All animals had started regaining weight by 1 day after surgery, and all had 
returned to pre-surgery weight by day 4 post-surgery. Body weight data are shown in Figure 4.1. 
This figure also illustrates body weight during the pre-surgical period when rats were chronically 
food-restricted for training in the Montoya staircase. 
Tail problems related to the rose Bengal administration developed in 6 rats during the 
31 day post-surgical period. The tails turned pink or purple and, over time, showed signs of 
necrosis. Working in close consultation with the Veterinarian, criteria were developed to 
humanely euthanize any rat showing sign of distress, pain, or tail infection. All rats that showed 
tail problems were monitored twice a day for the entire study period. Four rats were kept until 
the end of the study, whereas 2 rats had to be euthanized one day prior to the end of the study. 
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Table 4.1: Summary of physiological variables monitored during surgery. 
 
Group 
Oxygen Saturation 
(%) 
Pulse Rate  
(beats per minute) Temperature (°C) 
Mean ± 
SEM 
Range Mean ± 
SEM 
Range Mean ± 
SEM 
Range 
ISCHEMIA 
(n=15) 99.4 ± 0.1 
98 - 
100 
301.4 ± 
4.9 
256 - 
348 
36.8 ± 
0.1 
36.2 – 
37.7 
SHAM  
(n=3) 99.3 ± 0.3 
98 - 
100 
308.8 ± 
8.8 
287 - 
335 
36.8 ± 
0.3 
36.6 – 
37.9 
Means are calculated as the average of means for each rat over the surgical period. Ranges display the 
lowest and highest values in the group, to show inter-animal variability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Body weight (g) during the experimental period. Values are shown as mean ± SEM for ISCHEMIA 
(n= 15) and SHAM (n=3) groups. 
62  
4.3.2 Histological Outcomes 
 
Control (Sham) rats demonstrated no histological evidence of cortical damage. An 
infarct was present in 87% of rats exposed to photothrombotic stroke. The infarct volume varied 
from 5.7 mm3 to 12.8 mm3 in those 13/15 rats exposed to photothrombotic stroke. The 2 animals 
without visible infarcts experienced problems with rose Bengal dye injection. In both cases, the 
needle was inserted multiple times before the catheter could be positioned in the tail vein. 
Resistance while injecting rose Bengal was also reported, suggesting avascular leakage of the 
dye. The variation in infarct size is shown in Figure 4.2. 
 
 
 
Figure 4.2: Variation in total volume of infarct (mm3) among rats exposed to photothrombotic stroke 
(n=15). Two rats had no visible infarct. The infarcts of all other animals ranged from 5.7 mm3 to 12.8 
mm3. For labelling, animals with the same letter were caged together. 
 
 
 
 
Figure 4.3 shows a photograph of a coronal section, at 10x magnification, taken 
through the core of the lesion (~0.5 mm from Bregma) for 2 rats from the ISCHEMIA group. 
These sections demonstrate two differences commonly observed during the preparation of brain 
sections: (1) the shape of the lesion is different; and (2) the section on the left side shows that the 
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infarct (necrotic tissue) was lost during sectioning, while the infarct on the right side is intact. 
Inspection of coronal sections under the microscope at higher magnification (100x) revealed the 
necrotic area of infarct with an adjacent area of marked reactive gliosis. For most animals, the infarction 
extended through all cortical layers but did not affect subcortical structures. However, some animals 
showed damage to the underlying corpus callosum. 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
 
 
 
 
Figure 4.3: Photographs (10x magnification) of coronal sections taken at the core of the infarct for 2 animals, 
located at ~0.5mm from Bregma. (a) This photograph is representative of cases in which the necrotic tissue was lost 
during sectioning; (b) This is an example of a coronal section with intact infarcted tissue. Each section represents 
one of many different lesion shapes observed. The region of infarct is shown by the arrow. 
 
 
 
 
Figure 4.4 shows the variability in the locations of the infarcts in the brain cortex from the 
13 rats that had a visible infarct. Most animals had infarcts positioned less rostral and lateral than was 
targeted with the photothrombotic stroke planned. 
The infarct distribution and position in selected brain coordinates are illustrated in 
Figure 4.5 for the smallest (5.7 mm3) and largest (12.8 mm3) infarcts obtained. Both representations 
depict infarcts located in the forepaw area of sensorimotor cortex. 
Lesion volume (mm3) and location (coordinates of infarct in mm) are provided in Table 
4.2 for direct comparison for each ISCHEMIA rat. 
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Figure 4.4: Representation of the location of the infarct in the brain cortex of those ISCHEMIA rats with an 
observable infarct (n=13) in comparison to the intended placement (+2 mm to -1 mm anterior-posterior from 
Bregma and from +2 mm to +5 mm lateral of midline). Most infarcts are positioned less rostral than planned. 
None of the ISCHEMIA animals showed the lateralization proposed. For labelling, animals with the same letter 
were caged together. 
 
 
 
 
 
Figure 4.5: Area and regional distribution of two sample brains with the largest (12.8 mm3) and smallest (5.7 
mm3) infarcts are represented in coronal diagrams. The lesions were localized in the sensorimotor cortex, and 
targeted the area of forepaw. 
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Table 4.2: Summary of lesion location and size for ISCHEMIA animals. 
 
  Coordinate of Lesion Relative to 
Bregma (mm) 
 
Coordinate at Core of Lesion 
(mm) 
  
  Total Volume 
(mm3) 
Animal Anterior Posterior Medial Lateral   
A0 0.88 -1.6 1 3.5 5.7 
A1 2.2 -1.4 0.5 4 10.4 
B0 1.5 -2.04 1 4 6.3 
B1 2.2 -1.7 0.5 4 12.1 
C0 1.7 -1.8 0.5 3.5 11.0 
C1 2.3 -0.9 0.5 3.5 9.5 
D0 2.1 -1.8 0.5 4 11.5 
D1 2.08 -1.88 1 4 9.4 
D2 No infarct.       0 
E0 2.2 -1.3 1 4 10.8 
E1 No infarct.       0 
F0 2.5 -1.16 1 4 12.8 
F1 2.7 -1.3 0.3 4 11.8 
G0 2.08 -2.3 1 4 12.3 
G1 1.88 -1.8 0.5 3.5 7.9 
Mean 2.02 -1.61 0.72 3.85 8.8 
SEM 0.13 0.11 0.08 0.07 1.2 
 
For labelling, animals with the same letter were caged together. 
 
 
 
4.3.3 Behavioral Outcomes 
 
Montoya staircase tests confirmed that ISCHEMIC animals show a decline in reaching 
success after stroke, which then improves over time. Figure 4.6 shows that on day 3 after 
surgery, animals’ ability to retrieve and eat sugar pellets had declined to a mean (± SEM) of 
34.3 ± 7.3% of their baseline performance. After that, function started  improving,  and  by day 
15, the rats showed mean (± SEM) reaching ability of 60.5 ± 4.3% of their baseline 
performance. Mean (± SEM) reaching ability after 30 days was 65.5 ± 5.0% of baseline 
performance. Repeated measures ANOVA confirmed that there was a significant difference in 
reaching ability over time (F(2,24) = 14.9, p < 0.001), and post-hoc testing showed that 
performance on days 15 and 30 were not statistically different (t(12) = -0.96, p = 0.36). 
SHAM animals are plotted for illustration of normal function and were not used in statistical 
analysis due to small sample size. 
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Figure 4.6: Reaching success in the Montoya staircase test was impaired after stroke and improves 
over time, but there was incomplete recovery by d30. Data are expressed as mean (± SEM) % of baseline 
performance before stroke (day 3 = 34.3 ± 7.3; day 15 = 60.5 ± 4.3; day 30 = 65.5 ± 5.0). ISCHEMIA 
rats performed differently over time (F(2,24) = 14.9, p < 0.001), and there was no significant difference on 
performance between days 15 and 30 (t(12) = -0.96, p = 0.36). 
 
 
 
Figure 4.7 illustrates preferred/affected forepaw use in the cylinder test. ISCHEMIA 
rats showed a significant decline in the affected limb use for postural support, and the group 
mean showed complete recovery by 30 days. There was a statistically significant difference in % 
affected limb use over time (F(2,28) = 14.94, p < 0.001). Further post-hoc testing showed that 
there was a significant improvement in the use of affected paw for postural support from day 3 to 
day 30 (t(14) = -2.7, p = 0.018). Baseline values and day 30 values were not statistically different 
(t(14) = 2.63, p = 0.2). The mean % affected limb use on day 30 was 42.7%, as compared to the 
53.9% use at the baseline assessment. However, when examining individual rat performance, 
there was considerable variability. Only 2 animals in fact showed complete recovery, and 2 other 
animals had smaller than 10% deficits at 30d. 
a 
b 
b 
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Figure 4.7: ISCHEMIA rats used their affected limb for support in the cylinder significantly less after stroke 
(F(2,28) = 14.94, p < 0.001) and improved function significantly over 30 days (t(14) = -2.7, p = 0.018). Use of 
the preferred paw after 30 days was not statistically different than that at baseline (t (14) = 2.63, p = 0.2), 
showing complete recovery. 
 
 
 
 
Figure 4.8 shows the complete pattern of forepaw use in the cylinder in the 
ISCHEMIA rats over the 30 days after stroke. ISCHEMIA rats showed significant forelimb 
asymmetry for postural support, and this asymmetry changed over time (interaction between 
time and forepaw use) (F(4,84) = 7.96, p < 0.001). The concomitant use of both paws for support 
was significantly decreased on repeated testing (p = 0.001), and the use of the affected paw and 
the unaffected paw for unilateral support was approximately equal (p = 0.76). 
a 
a 
b 
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Figure 4.8: Pattern of limb use in the ISCHEMIA group for postural support in the cylinder was significantly 
different over time (F(4,84) = 7.96, p < 0.01) (interaction term). The bilateral use of forelimbs was 
decreased over time (p = 0.001), whereas affected and unaffected paws were used unilaterally approximately 
the same (p = 0.76). n=15. 
 
 
4.3.4 Relationship between Infarct Size and Behavioral Outcomes 
 
To examine if performance in the Montoya staircase was related to the size of the 
stroke (infarct volume), the deficit in this task was calculated as the percent change in 
performance between the pre-stroke baseline assessment and the test on post-stroke d 3, 15 and 
30. Figure 4.9 shows that there was a significant positive correlation on d3 (r2 = 0.47, p = 0.006, 
Pearson’s correlation). Figures 4.10 and 4.11 show that infarct volume and extent of deficit in the 
task were not significantly correlated on d 15 (r2 = 0.14, p = 0.20, Pearson’s correlation) or d 30 
(r2 = 0.19, p = 0.14, Pearson’s correlation). 
 
To examine the extent to which performance in the cylinder test was related to 
the size of the stroke (infarct volume), the deficit in this task was calculated as the percent 
change in performance in between the pre-stroke baseline assessment and the test on post-
stroke days (d 3 and 30). Figures 4.12 and 4.13 demonstrate that there was a significant 
positive correlation on d3 (r2  = 0.62, p < 0.001, Pearson’s correlation) but not on d30 (r2  
= 0.02, p = 0.62, Pearson’s correlation).  
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Figure 4.9: The d3 deficit in the Montoya staircase significantly increased with increasing infarct volume 
(r2 =0.47, p = 0.006, Pearson’s correlation) in rats following photothrombotic stroke. Deficit (%) was 
calculated as 100- [(pellets eaten on day 3/ pellets eaten at baseline) x 100]. n = 13. 
 
 
 
 
 
 
 
Figure 4.10: The d15 deficit in the Montoya staircase was not significantly correlated with infarct volume 
(r2 = 0.14, p = 0.20, Pearson’s correlation) in rats following photothrombotic stroke. Deficit was calculated as 
100- [(pellets eaten on day 15/ pellets eaten at baseline) x 100]. n = 13. 
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Figure 4.11: The deficit in the Montoya staircase on d 30 after photothrombotic stroke was not 
significantly correlated with infarct volume (r2 = 0.19, p = 0.14, Pearson’s correlation). Deficit was 
calculated as 100- [(pellets eaten on day 15/ pellets eaten at baseline) x 100]. n= 13. 
 
 
 
 
 
 
Figure 4.12:  The  deficit  in  the  cylinder  test  on  d3  after  photothrombotic  stroke  was significantly 
correlated to infarct volume (r2 = 0.62, p < 0.001, Pearson’s correlation). n = 15. 
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Figure 4.13: The deficit in the cylinder test on d30 after photothrombotic stroke did not show significant 
correlation with infarct volume (r2 = 0.02, p = 0.62, Pearson’s correlation). n = 15. 
 
 
The presence of tail necrosis could influence performance in the behavioural tasks 
and could also be a marker of incomplete dye infusion (and thus predictive of smaller infarct 
size). Thus, multiple regression analysis was performed to determine if the presence of tail 
necrosis affected the dependent variables: d 3, 15 and 30 Montoya staircase performance, d3 and 
30 cylinder test performance, and infarct volume. The prediction model indicated that tail 
necrosis had a significant effect on all variables when pooled together (F(6, 6) = 7.374, p = 
0.014). Partial correlations revealed that tail health problems were negatively correlated with 
infarct size (β = -0.542, p = 0.03); the presence of tail problems explained approximately 24% of 
the infarct size variance (r2 = 0.24). Also, tail problems had a positive correlation with Montoya 
 
performance on day 30; that is, rats with a tail problem had smaller chronic deficits in the 
Montoya staircase (β = 0.707, r2 = 0.50, p = 0.003). 
 
4.4 Discussion 
The main objective of the present study was to determine the success and reliability 
of the photothrombotic stroke techniques for inducing cortical stroke. A visible infarct was 
apparent in 87% of the rats. As intended, the infarct was located in the sensorimotor cortex and 
removed a small part of the forelimb representation of the neocortex as previously described in 
published maps (Kleim, Barbay et al. 1998, Donoghue, Wise 1982, Neafsey, Bold et al. 1986). 
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Although some brains also showed damage to the corpus callosum, other subcortical regions 
were not damaged, and previous work has shown that this lesion extension could be due to 
degeneration of efferent fibers from the motor cortex and should not affect function (Karl, 
Alaverdashvili et al. 2010). The photothrombotic stroke surgery was also successful in that the 
minimal invasiveness allowed for rapid post-surgical recuperation and minimal distress to the 
animals. The weight loss after surgery was small and quickly recovered, which reinforces the 
model as a good one for addressing the interaction between nutritional status and stroke. 
However, the extent of variability in the size, shape, and exact placement of the 
infarct suggests that further technical refinements are needed. To allow for comparison of study 
variability in infarct volume [mean (± SEM) of 8.8 ± 1.2 mm3] with other studies reporting 
different mean infarct volumes, the coefficient of variation was calculated to be 47%. The 
variability associated with this model is usually reported to be considerably lower than observed 
in the current study. One study with a mean infarct size similar to ours (12 mm3) reported a 
coefficient of variation of 19% (Yao, Sugimori et al. 2003). Another study with similar methods 
but smaller infarcts (2.84 mm3), showed a coefficient of variation of 14% (Moon, Alaverdashvili 
et al. 2009). We also found a large variability in lesion shape, whereas photothrombotic stroke in 
the cortex usually results in a triangular shaped infarct (Jablonka, Burnat et al. 2010, Moon, 
Alaverdashvili et al. 2009, Imbrosci, Eysel et al. 2010, Schmidt, Bruehl et al. 2012). There was 
also some misplacement of the infarct relative to the intended brain coordinates. 
One of the variables contributing to the large variability is difficulty in tail vein 
injection of the rose Bengal dye in some rats. Multiple attempts at correctly positioning the 
catheter could have caused dye leakage, and the high concentration of dye in the stock solution 
could have caused direct endothelial damage. The result in these cases was that less than the 
optimal dye dose reached the targeted area. Increased variability could also be attributed to some 
variation in skull thinning and quality of skull area demarcation with the drill. Our procedure of 
illuminating the skull with the laser prior to dye injection may have contributed to variability in 
infarct shape and volume. It is possible that the cortical vessels were affected by the heat 
produced by irradiation and that some clotting was initiated before the dye reached the area 
(Nishimura, Schaffer et al. 2006). This variable, as well as difficulty in thinning the bone in the 
lateral portion of the skull, may also have contributed to some misplacement of lesions. 
This study was also designed to assess the extent and consistency of the motor 
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alterations caused by stroke. The Montoya staircase results showed that our model of 
photothrombotic stroke resulted in impairments in skilled reaching for sugar pellets. On day 3 
after stroke, mean reaching success with the affected paw was 34.3 % of baseline performance, 
and this recovered to 60.5% of baseline values by day 15. One study that assessed reaching 
ability after focal ischemia induced by endothelin-1 reported reaching success of 38.5 % of 
baseline performance after 15 days (Biernaskie, Corbett 2001). However, the infarcts in this 
study were larger than ours, the rats were younger, and the stroke affected not only the 
sensorimotor cortex, but also the lateral portion of the caudate putamen. That explains their 
deficit on day 15 being similar to our deficit on day 3. Our results also agree with another report 
which showed that with a lesion similar to our largest lesion (~ 12 mm2), the reaching ability in 
the Montoya staircase at 5 days after stroke was approximately 25% of baseline performance 
(MacLellan, Keough et al. 2011). Our analysis also showed a positive correlation between the 
presence of tail necrosis and performance on day 30 in the Montoya staircase. This is expected 
since post-surgical tail problems predict inefficient delivery of rose Bengal and smaller infarcts, 
and rats with smaller infarcts have a greater tendency to recover. The cylinder test results 
showed that the affected limb was used for support significantly less after stroke, and the mean 
deficit on day 3 was 56.3 %. Other studies have shown similar deficits. One group, using the 
endothelin-1 model of stroke, evaluated affected limb use in the cylinder on day 5 after stroke, 
and reported a 43.5% deficit (MacLellan, Keough et al. 2011). Another group, using the 
photothrombotic stroke model, reported a deficit of 52.1% on day 1 after stroke (Shanina, 
Schallert et al. 2006). 
The functional deficit in the cylinder and Montoya staircase tests on day 3 after 
stroke was correlated with infarct volume measured at 30 days post-stroke. This was expected 
since a larger infarct to the motor cortex usually produces larger functional abnormalities 
(Grabowski, Brundin et al. 1993, Baird, Meldrum et al. 2001, Roof, Schielke et al. 2001). This 
relationship was lost on post-stroke days 15 and 30 on the Montoya staircase test and on day 30 
in the cylinder test. These results are in agreement with previous studies demonstrating that the 
rate of functional recovery depends not only on the extent of infarct, but also on plasticity 
mechanisms that assist this recovery (Levin, Kleim et al. 2009, Cramer 2008). 
An important study finding was that recovery of reaching function in the Montoya 
staircase was incomplete (65.5% of baseline performance) at 30 days after stroke. The cylinder 
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results in this respect were particularly influenced by the high stroke model variability. Whereas 
27% of rats either completely recovered the use of the affected limb for support or had very 
small deficits (2 – 3%) by the end of the study, the other 73% recovered to only 67% of pre- 
stroke baseline performance. It is predicted that technical refinements that further reduce the 
variability in the photothrombotic stroke model in future should thus result in the desired 
functional outcome. Although it is difficult to compare our results directly to the clinical reality, 
the majority of patients who survive ischemic stroke and show motor impairments have 
incomplete functional recovery that varies from notable to limited; skilled functions are more 
difficult to recover than support functions (reviewed in Stinear 2010). 
There were two methodological limitations of this study that can be improved in 
future experimental designs. The first was the use of the cylinder test for determination of paw 
preference and thus infarct placement. Most animals are extremely ambidextrous, and the 
interchangeable use of the paws is more noticeable in unskilled movements (Whishaw 1992, 
Ρençe 2002). Since the Montoya staircase assesses skilled function, the probability of finding  
real paw preference would be greater if this test had been used to assign paw preference. A 
second limitation also noted in the Discussion of Chapter 3 is that Montoya staircase testing on at 
least two independent days for each time point would have better captured true variability. By 
testing twice in the same day, the estimate of consistency and extent of recovery in this study  
was possibly compromised. However, it is also noted that additional testing days increase risk 
that the assessment could also serve a rehabilitative function (Clarke, Mala et al. 2009). 
In summary, this study allowed for the methodological development of the stroke 
photothrombotic model and two well accepted behavioural protocols (Montoya staircase and 
cylinder tests) that work in combination with the model. While the basic methods were 
established for inducing stroke, further refinements are needed to reduce variability in infarct 
size and functional outcome. 
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CHAPTER 5 
DISCUSSION 
 
 
5.1 Conclusions 
 
The studies described in this thesis resulted in two rat models required for future 
study of the PEM that develops after stroke. These models, with some additional refinements, 
form a good basis for addressing the hypothesis that PEM that develops after stroke will impair 
motor neuroplasticity. Separately, the two experiments established both a nutritional model to 
cause the desired PEM in adult rats, and a focal ischemia model to mimick the human stroke 
patient. 
The PEM model development described in Chapter 3 yielded some novel findings. 
First, a 0.5% protein diet fed for 31 days achieved the desired goal of acute moderate PEM in 
adult (16 week old) rats. Also, we confirmed previous findings from my laboratory that PEM 
can independently cause an acute phase response, although there were specific differences when 
compared against the acute phase reactant response observed in protein-energy malnourished 
adolescent rats (Smith, Andrade Ramos et al. 2013). The current study also demonstrated the 
absence of an effect of PEM on skilled reaching ability in the adult rat. Although protein-energy 
malnutrition is associated with diminished muscle strength in elderly individuals (reviewed in 
Mithal, Bonjour et al. 2012), there were no previous data on forelimb skilled function. This 
finding is especially important for future studies of the effects of PEM on this well-established 
measure of motor deficit caused by experimental stroke. Future stroke studies should also 
include malnourished sham-operated rats to address the possibility of independent effects of 
PEM on skilled reaching, as this could arise with longer exposure to PEM. 
The study described in Chapter 4 established the initial methodology for the 
photothrombotic stroke model. Most surgeries were effective in inducing an infarct in the 
forepaw functional domain of the neocortex. Histological damage was translated to functional 
outcomes in the sense that animals with infarcted brains showed behavioral abnormalities. 
Although rats improved their performance over time, the final functional testing after 30 days 
showed incomplete recovery in 70% of rats. Evidence for the lack of invasiveness with this 
stroke model was observed in the post-surgical period, during which rats had minimal weight 
loss and showed no signs of lethargy. However, the extent of variability in the size, shape, and 
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exact placement of the infarct combined with some cases of tail necrosis indicate that further 
technical refinements are required. 
 
5.2 Strengths and Limitations 
The major strength of the studies performed herein is the development of animal 
models that will allow for carefully controlled analysis of the effects of post-stroke nutritional 
status on functional recovery. Clinical studies have not been able to establish cause and effect 
relationships between PEM and outcome from stroke. Also, a clinical study would not be able 
to examine exact mechanisms and carefully analyse brain biochemistry, which is possible with 
animal research (Lieschke, Currie 2007, Graham, McCullough et al. 2004). Moreover, the two 
studies in this thesis were carefully designed to mimick the human conditions of stroke and 
malnutrition as observed in patients after stroke. Rat studies permit strict control over diet 
consumption, lifestyle and body weight status (Lieschke, Currie 2007, Small, Buchan 2000). 
Performing the two model-building experiments separately also allowed for isolating a number 
of possible confounding variables and analysing the causes for the outcome measures 
individually. 
Another strong point of the research design was the choice of behavioral tests for 
both studies. Although time-consuming, rats can be readily trained in the Montoya staircase, and 
a high proportion are able to reach criteria, a feature noticed by other groups as well (Pagnussat, 
Michaelsen et al. 2009, Abrous, Dunnett 1994). This is in contrast to another skilled reaching 
test, the single pellet reach test, in which many rats cannot reach criteria and have to be 
eliminated from the study (Silasi, Hamilton et al. 2008). Neither protein-energy malnourished 
nor stroke rendered rats were unable to perform the task, although in the latter case, rats clearly 
showed the expected disability. The most positive aspect of the behavioral tests chosen is the 
fact that they assess different characteristics of forepaw function. The Montoya staircase 
assessed skilled function and is a food rewarded test, which means that the rat is able to obtain a 
treat (sugar pellet) for performing well (Montoya, Campbell-Hope et al. 1991). The cylinder test 
measured use of the limb for support and is a non-baited test in that the rat is not rewarded for 
doing the task (Gharbawie, Whishaw et al. 2004). The lack of food reward is especially 
important in nutrition studies since it prevents confounding variables such as increased energy 
intake or alterations in protein/carbohydrate ratio or intake of experimental diet. An asset of the 
77  
Montoya staircase is that the function of the two forelimbs can be investigated separately 
(Grabowski, Brundin et al. 1993), although in the thesis research, the task was used to assess 
function of only the affected or preferred paw. One limitation of the experimental design is that 
the cylinder test was not included in the PEM study and thus, we cannot infer about how the 
evolving malnutrition would affect the use of limbs for postural support. One of the problems of 
not conducting the cylinder test in the malnutrition study is that there was a decrease in the 
number of wall touches with increased exposure to the task in the stroke study. Should PEM also 
affect the number of touches, for example by altering motivation to explore, this would reduce 
test sensitivity and potentially introduce a confounding variable (Gharbawie, Whishaw et al. 
2004). 
A major asset of the PEM study was the creation of two different PEM prototypes by 
manipulating the protein content of the diet. The main limitation was limited sensitivity of the 
test used to assess whether PEM altered motivation to reach for a sugar pellet. After performing 
this test, it became evident that it is a relatively crude test subject to several errors, which may 
account for the large variability observed among animals. When considering within-animal 
variance, it was noticed that the rats became more comfortable with the task over time, as 
assessed by less time spent rearing and less urination and defecation in the testing cage. This 
could be another flaw of this assessment, since the goal was to assess motivation and not 
acclimatization. It is further noted that the design tested only the effects of evolving malnutrition 
on motivation to obtain a sugar pellet, and the results could differ with PEM presenting after a 
stroke. Human studies have shown, for example, that stroke causes altered taste perceptions 
(Dutta, Josiah et al. 2013). 
Another limitation of the malnutrition study concerns the grouping of the animals. 
Cage mates were not weight-paired, which in some cases rendered a larger, presumably more 
dominant rat in the same cage with a smaller dominated one. This difference would have been 
exaggerated during the training period for the Montoya staircase when animals were chronically 
food-restricted. This resulted in some cases in which one rat ate substantially more than the 
other, which affected the baseline weight for starting the protein-restricted diets (Baenninger 
1970). 
The photothrombotic stroke model chosen for the second study had the advantage of 
being well-established in the literature (Watson, Dietrich et al. 1985, Dietrich, Busto et al. 1987, 
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Watson 1998, Diederich, Quennet et al. 2012b, Jablonka, Burnat et al. 2010, Sulejczak, 
Ziemlinska et al. 2007), which gave insight into potential problems before they happened. The 
most positive aspect of this model, relative to other rat stroke models, is the previously reported 
lack of surgical invasiveness and the fast post-surgical recovery (Dietrich, Busto et al. 1987), 
which was confirmed in this study. This feature is very important for future study of post-stroke 
PEM in order to minimize the confounding influence of the stress response to surgery on 
nutritional requirements and nutritional status. 
This study was a good first step towards establishing the photothrombotic model in 
our laboratory. Although well-established in the literature, there is no one universally accepted 
standard for the methodology (Dietrich, Busto et al. 1987, Maxwell, Dyck 2005, Sulejczak, 
Ziemlinska et al. 2007, Schmidt, Bruehl et al. 2012), which renders each laboratory responsible 
for establishing and refining its own. In the case of my laboratory, some refinements are still 
needed to overcome some inconsistencies in infarct volume and placement and functional 
outcome. The damage caused to the tails of some rats by the rose Bengal injection proved to be 
an important limitation. However, my laboratory has recently completed a pilot study 
demonstrating that using both a lower dose of rose Bengal (10-20 mg/kg) and a less 
concentrated stock solution for injection can induce a reproducible brain infarct while 
minimizing any side effects related to dye injection. 
There are many variables that can influence performance on behavioural tests, and 
most rely on the individuality of each rat. Although there was a general pattern in behaviour in 
both the Montoya staircase and the cylinder test after stroke, each rat had an individual pattern of 
performance and recovery that could not always be accounted for by the size of the brain infarct. 
Different rat strains are known to behave differently in the Montoya staircase, but in addition, 
there is variability within strains, especially in the training phase, but also in the maximum level 
of performance (Nikkhah, Rosenthal et al. 1998). Similarly, we noticed that rats that looked 
visibly more distressed had fewer wall touches in the cylinder. 
 
5.3 Future Directions 
 
Although the two studies together established essential basic methodology, 
additional adjustments are necessary before using the models to study the influence of post-
stroke PEM. A wash-out period should be added between any behavioural training period that 
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requires food restriction and stroke surgery and/or randomization into experimental diet groups. 
This extra step will avoid the early differences in food intake observed in the present study. 
Also, a pilot study since performed in my laboratory suggests that it will be possible to train rats 
to reach in the Montoya staircase without food restriction (unpublished findings), which will 
offer a considerable advantage for future nutrition-related studies. It would also be interesting to 
examine the effects of a pre-stroke Western diet, which frequently contains a higher content of 
refined grains and sugar products and excessive saturated and trans fatty acids (Cordain, Eaton et 
al. 2005). This would be of interest because a high proportion of people are eating foods high in 
fat and sugars (Sherzai, Heim et al. 2012). After feeding the Western diet for a few weeks, the 
influence of post-stroke PEM would be an even better mimick of the clinical scenario for many 
patients. This Western diet on its own can exert detrimental effects on stroke outcome (Langdon, 
Clarke et al. 2011), so it would be interesting to study the combined effects of pre-stroke  
Western diet and post-stroke PEM. 
Although all behavioral training and testing for the Montoya staircase was done in the 
active (dark) phase of the cycle, it would be advantageous to complete this testing during the day 
to increase efficiency and expand flexibility for scheduling available for the testing. Other groups 
have successfully trained and tested in the light phase (Mestriner, Pagnussat et al. 2011; Auriat, 
Colbourne 2009); however, there are also reports of lower activity during this period (Stephenson, 
Lim et al. 2012). A pilot study in my laboratory now suggests that both training and testing can be 
accomplished during the light phase without increasing the training period excessively 
(unpublished findings). 
The studies described in this thesis with adult rats have provided the first step 
towards studying older animals. The Stroke Treatment Academic Industry Roundtable (STAIR), 
which aims to advance the development of acute and restorative stroke therapies, has 
recommended that after initial evaluations in young, healthy male animals, further preclinical 
stroke studies should be performed in females, aged animals, and animals with comorbid 
conditions such as hypertension, diabetes, and hypercholesterolemia (Albers, Goldstein et al. 
2011). The future planned studies addressing PEM as a comorbidity factor meets the latter goal, 
but will focus on nutrition as a commonly overlooked determinant of outcome after stroke. 
Future studies of PEM should also include both aged and female rats to more completely 
mimick the clinical reality. However, studies with older animals are expensive, and a surgical 
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model of stroke may well need further adjustment before application to aged rats that also will 
require extended care and attention. Studies with female rats require strict monitoring of 
hormonal fluctuations, which could affect many outcome variables. Such challenges are best 
addressed after an experimental model of stroke is very well-established and reliable in the 
adult. 
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